 | Up a level |
Shumilov, Evgenii; Mazzeo, Paolo; Ghandili, Susanne; Künstner, Axel; Weidemann, Sören; Banz, Yara; Ströbel, Philipp; Pollak, Matthias; Kolloch, Lina; Beltraminelli, Helmut; Kerkhoff, Andrea; Mikesch, Jan-Henrik; Schliemann, Christoph; Haase, Detlef; Wulf, Gerald; Legros, Myriam; Lenz, Georg; Feldmeyer, Laurence; Pabst, Thomas; Witte, Hanno; ... (2024). Diagnostic management of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in close interaction with therapeutic considerations. Annals of hematology, 103(5), pp. 1587-1599. Springer-Verlag 10.1007/s00277-023-05587-7
van der Maas, Niek G; Versluis, Jurjen; Nasserinejad, Kazem; van Rosmalen, Joost; Pabst, Thomas; Maertens, Johan; Breems, Dimitri; Manz, Markus; Cloos, Jacqueline; Ossenkoppele, Gert J; Floisand, Yngvar; Gradowska, Patrycja; Löwenberg, Bob; Huls, Gerwin; Postmus, Douwe; Pignatti, Francesco; Cornelissen, Jan J (2024). Bayesian interim analysis for prospective randomized studies: reanalysis of the acute myeloid leukemia HOVON 132 clinical trial. Blood cancer journal, 14(56) Nature Publishing Group 10.1038/s41408-024-01037-3
Schmid, Jonas Andreas; Festl, Yasmin; Severin, Yannik; Bacher, Vera; Kronig, Marie-Noëlle; Snijder, Berend; Pabst, Thomas (2024). Efficacy and feasibility of pharmacoscopy-guided treatment for acute myeloid leukemia patients who have exhausted all registered therapeutic options. Haematologica - the hematology journal, 109(2), pp. 617-621. Ferrata-Storti Foundation 10.3324/haematol.2023.283224
Heini, Alexander D; Bacher, Ulrike; Pabst, Thomas (2024). Identification of novel targets for immunotherapies in subsets of patients with diffuse large B-cell lymphoma (DLBCL). British journal of haematology, 204(2), pp. 389-390. Wiley-Blackwell 10.1111/bjh.19195
Bacher, Vera; Shumilov, Evgenii; Pabst, Thomas (2024). Increasing insight in the value of repetitive COVID-19 vaccination in patients with haematological malignancies in the Omicron era. British journal of haematology, 204(2), pp. 386-388. Wiley 10.1111/bjh.19221
Fuchs, Michael; Jacob, Anne Sophie; Kaul, Helen; Kobe, Carsten; Kuhnert, Georg; Pabst, Thomas; Greil, Richard; Bröckelmann, Paul J; Topp, Max S; Just, Marianne; Hertenstein, Bernd; Soekler, Martin; Vogelhuber, Martin; Zijlstra, Josée M; Keller, Ulrich Bernd; Krause, Stefan W; Dührsen, Ulrich; Meissner, Julia; Viardot, Andreas; Eich, Hans-Theodor; ... (2024). Follow-up of the GHSG HD16 trial of PET-guided treatment in early-stage favorable Hodgkin lymphoma. Leukemia, 38(1), pp. 160-167. Springer Nature 10.1038/s41375-023-02064-y
Passweg, Jakob R; Baldomero, Helen; Ansari, Marc; Arber, Caroline; Chalandon, Yves; Daskalakis, Michael; Diepold, Miriam; Diesch-Furlanetto, Tamara; Duchosal, Michel A; Gerull, Sabine; Güngör, Tayfun; Heim, Dominik; Hitz, Felicitas; Holbro, Andreas; Masouridi-Levrat, Stavroula; Nair, Gayathri; Novak, Urban; Pabst, Thomas; Renner, Christoph; Stussi, Georg; ... (2024). Hematopoietic cell transplantation and cellular therapies in Switzerland. Evolution over 25 years. A report from the stem cell transplantation and cellular therapies working groups of the SBST 1997-2021. Hematological oncology, 42(1), e3241. Wiley 10.1002/hon.3241
Perroud, Camille; Thurian, Dario; Andres, Martin; Künzi, Arnaud; Wiedemann, Gertrud; Zeerleder, Sacha; Bacher, Ulrike; Pabst, Thomas; Banz, Yara; Porret, Naomi; Rebmann, Ekaterina (2023). Effect of MAPK activation via mutations in NRAS, KRAS and BRAF on clinical outcome in newly diagnosed multiple myeloma. Hematological oncology, 41(5), pp. 912-921. Wiley 10.1002/hon.3208
Chen, Jia; Labopin, Myriam; Pabst, Thomas; Zhang, Xi; Jiang, Erlie; Tucci, Alessandra; Cornelissen, Jan; Meijer, Ellen; Khevelidze, Irma; Polge, Emmanuelle; Wu, Depei; Mohty, Mohamad; Gorin, Norbert-Claude (2023). Autologous stem cell transplantation in adult patients with intermediate-risk acute myeloid leukemia in first complete remission and no detectable minimal residual disease. A comparative retrospective study with haploidentical transplants of the global committee and the ALWP of the EBMT. Bone marrow transplantation, 58(12), pp. 1322-1330. Nature Publishing Group 10.1038/s41409-023-02070-9
Tettero, Jesse M; Buisman, Yara; Ngai, Lok Lam; Bachas, Costa; Gjertsen, Bjorn T; Kelder, Angèle; van de Loosdrecht, Arjan A; Manz, Markus G; Pabst, Thomas; Scholten, Willemijn; Ossenkoppele, Gert J; Cloos, Jacqueline; de Leeuw, David C (2023). Prognostic Significance of Measurable Residual Disease Detection by Flow Cytometry in Autologous Stem Cell Apheresis Products in AML. HemaSphere, 7(12), e981. Wolters Kluwer Health 10.1097/HS9.0000000000000981
Keil, Felix; Müller, Antonia M S; Berghold, Andrea; Riedl, Regina; Buxhofer-Ausch, Veronika; Schuster, Judith; Vorburger, Corinne; Böhm, Alexandra; Panny, Michael; Nösslinger, Thomas; Greil, Richard; Samaras, Panagiotis; Bencker, Celine; Rütti, Markus; Pabst, Thomas (2023). BendaEAM versus BEAM as conditioning regimen for ASCT in patients with relapsed lymphoma (BEB): a multicentre, randomised, phase 2 trial. EClinicalMedicine, 66(102318), p. 102318. Elsevier 10.1016/j.eclinm.2023.102318
Shumilov, Evgenii; Boyadzhiev, Hristo; Mazzeo, Paolo; Akhoundova, Dilara; Daskalakis, Michael; Novak, Urban; Lenz, Georg; Bacher, Ulrike; Pabst, Thomas (2023). CAR-T Cell Therapy Shows Similar Efficacy and Toxicity in Patients With DLBCL Regardless of CNS Involvement. HemaSphere, 7(12), e984. Wolters Kluwer Health 10.1097/HS9.0000000000000984
Beyeler, Morin; Rea, Erich; Weber, Loris; Belachew, Nebiyat Filate; Barvulsky Aleman, Enrique; Kielkopf, Moritz; Kurmann, Christoph C; Grunder, Lorenz; Piechowiak, Eike Immo I; Meinel, Thomas R; Heldner, Mirjam R; Seiffge, David; Pilgram-Pastor, Sara; Dobrocky, Tomas; Pabst, Thomas; Berger, Martin D; Jung, Simon; Arnold, Marcel; Gralla, Jan; Fischer, Urs; ... (2023). Susceptibility vessel sign, a predictor of long-term outcome in patients with stroke treated with mechanical thrombectomy. (In Press). Journal of neurointerventional surgery BMJ Publishing Group 10.1136/jnis-2023-020793
Sanz, Jaime; Labopin, Myriam; Pabst, Thomas; Versluis, Jurjen; Van Gorkom, Gwendolyn; Meijer, Ellen; Gedde-Dahl, Tobias; Montoro, Juan; Arcese, William; Pérez-Simón, Jose Antonio; Schaap, Nicolaas; Maertens, Johan; Vrhovac, Radovan; Lanza, Francesco; Gorin, Norbert Claude; Mohty, Mohamad; Ciceri, Fabio (2023). Etoposide plus cytarabine versus cyclophosphamide or melphalan in busulfan-based preparative regimens for autologous stem cell transplantation in adults with acute myeloid leukemia in first complete remission: a study from the Acute Leukemia Working Party of the EBMT. Bone marrow transplantation, 58(11), pp. 1197-1202. Nature Publishing Group 10.1038/s41409-023-02075-4
Pabst, Thomas; Papayannidis, Cristina; Demirkan, Fatih; Doronin, Vadim; Fogliatto, Laura M; Guttke, Christina; Gyan, Emmanuel; Hamad, Nada; Herrera, Pilar; Hultberg, Anna; Jacobs, Julie; Johnson, Amy J; Langlois, Angélique; Ma, Xuewen; Martinelli, Giovanni; Arnan, Montserrat; Müller, Rouven; Nottage, Kerri; Ofran, Yishai; Özcan, Muhit; ... (2023). Cusatuzumab plus azacitidine in newly diagnosed acute myeloid leukaemia ineligible for intensive chemotherapy (CULMINATE): part one of a randomised, phase 2, dose optimisation study. The Lancet. Haematology, 10(11), e902-e912. Elsevier 10.1016/S2352-3026(23)00207-7
Tettero, Jesse M; Ngai, Lok Lam; Bachas, Costa; Breems, Dimitri A; Fischer, Thomas; Gjertsen, Bjorn T; Gradowska, Patrycja; Griskevicius, Laimonas; Janssen, Jeroen J W M; Juliusson, Gunnar; Maertens, Johan; Manz, Markus G; Pabst, Thomas; Passweg, Jakob; Porkka, Kimmo; Valk, Peter J M; Löwenberg, Bob; Ossenkoppele, Gert J; Cloos, Jacqueline (2023). Measurable residual disease-guided therapy in intermediate-risk acute myeloid leukemia patients is a valuable strategy in reducing allogeneic transplantation without negatively affecting survival. Haematologica - the hematology journal, 108(10), pp. 2794-2798. Ferrata-Storti Foundation 10.3324/haematol.2022.282639
Maru, Bruktawit; Messikommer, Alessandra; Huang, Linhui; Seipel, Katja; Kovecses, Olivia; Valk, Peter J M; Theocharides, Alexandre P A; Mercier, Francois E; Pabst, Thomas; McKeague, Maureen; Luedtke, Nathan W (2023). PARP-1 improves leukemia outcomes by inducing parthanatos during chemotherapy. Cell reports. Medicine, 4(9), p. 101191. Elsevier 10.1016/j.xcrm.2023.101191
Sauer, Stephanie Tina; Christner, Sara Aniki; Schlaiß, Tanja; Metz, Corona; Schmid, Andrea; Kunz, Andreas Steven; Pabst, Thomas; Weiland, Elisabeth; Benkert, Thomas; Bley, Thorsten Alexander; Grunz, Jan-Peter (2023). Diffusion-weighted Breast MRI at 3 Tesla: Improved Lesion Visibility and Image Quality with a Combination of Water-excitation and Spectral Fat Saturation. Academic radiology, 30(9), pp. 1773-1783. Elsevier 10.1016/j.acra.2023.01.014
Bacher, Ulrike; Shumilov, Evgenii; Pabst, Thomas (2023). Benefit of repeated COVID-19 vaccination for patients with B-cell malignancies. British journal of haematology, 202(6), pp. 1081-1083. Wiley-Blackwell 10.1111/bjh.19005
Messerli, Christian; Wiedemann, Gertrud; Porret, Naomi; Nagler, Michael; Seipel, Katja; Jeker, Barbara; Novak, Urban; Zeerleder, Sacha; Bacher, Ulrike; Pabst, Thomas (2023). Correlation of peripheral chimeric antigen receptor T-cell (CAR-T cell) mRNA expression levels with toxicities and outcome in patients with diffuse large B-cell lymphoma (DLBCL). Turkish journal of haematology, 40(3), pp. 187-196. Turkish Society of Haematology 10.4274/tjh.galenos.2023.2023.0136
Seipel, Katja; Kohler, Scarlett; Bacher, Ulrike; Pabst, Thomas (2023). HSP90 Inhibitor PU-H71 in Combination with BH3-Mimetics in the Treatment of Acute Myeloid Leukemia. Current issues in molecular biology, 45(9), pp. 7011-7026. MDPI 10.3390/cimb45090443
Maechler, Melanie; Bacher, Ulrike; Daskalakis, Michael; Nilius, Henning; Nagler, Michael; Mansouri Taleghani, Behrouz; Jeker, Barbara; Pabst, Thomas (2023). Long-term safety of the stem cell releasing compound plerixafor for peripheral stem cell collection in myeloma patients. Hematological oncology, 41(3), pp. 583-586. Wiley 10.1002/hon.3055
Pabst, Thomas; Vey, Norbert; Adès, Lionel; Bacher, Ulrike; Bargetzi, Mario; Fung, Samson; Gaidano, Gianluca; Gandini, Domenica; Hultberg, Anna; Johnson, Amy; Ma, Xuewen; Müller, Rouven; Nottage, Kerri; Papayannidis, Cristina; Recher, Christian; Riether, Carsten; Shah, Priya; Tryon, Jeffrey; Xiu, Liang and Ochsenbein, Adrian F (2023). Results from a phase I/II trial of cusatuzumab combined with azacitidine in patients with newly diagnosed acute myeloid leukemia who are ineligible for intensive chemotherapy. Haematologica - the hematology journal, 108(7), pp. 1793-1802. Ferrata-Storti Foundation 10.3324/haematol.2022.281563
Haefliger, David; Marzolini, Catia; Lamoth, Frederic; Pabst, Thomas; Buclin, Thierry; Livio, Francoise (2023). Clinically relevant bidirectional drug-drug interaction between midostaurin and voriconazole. British journal of clinical pharmacology, 89(7), pp. 2304-2308. Wiley-Blackwell 10.1111/bcp.15743
Hilberink, Jacobien R; van Zeventer, Isabelle A; Chitu, Dana A; Pabst, Thomas; Klein, Saskia K; Stussi, Georg; Griskevicius, Laimonas; Valk, Peter J M; Cloos, Jacqueline; van de Loosdrecht, Arjan A; Breems, Dimitri; van Lammeren-Venema, Danielle; Boersma, Rinske; Jongen-Lavrencic, Mojca; Fehr, Martin; Hoogendoorn, Mels; Manz, Markus G; Söhne, Maaike; van Marwijk Kooy, Rien; Deeren, Dries; ... (2023). Age and sex associate with outcome in older AML and high risk MDS patients treated with 10-day decitabine. Blood cancer journal, 13(1), p. 93. Springer Nature 10.1038/s41408-023-00850-6
Seipel, Katja; Abbühl, Mariesol; Bacher, Vera; Nilius, Henning; Daskalakis, Michael; Pabst, Thomas (2023). Clinical Impact of Single Nucleotide Polymorphism in CD-19 on Treatment Outcome in FMC63-CAR-T Cell Therapy. Cancers, 15(11) MDPI AG 10.3390/cancers15113058
Ngai, Lok Lam; Hanekamp, Diana; Janssen, Fleur; Carbaat-Ham, Jannemieke; Hofland, Maaike A M; Fayed, Mona M H E; Kelder, Angèle; Oudshoorn-van Marsbergen, Laura; Scholten, Willemijn J; Snel, Alexander N; Bachas, Costa; Tettero, Jesse M; Breems, Dimitri A; Fischer, Thomas; Gjertsen, Bjorn T; Griskevicius, Laimonas; Juliusson, Gunnar; van de Loosdrecht, Arjan A; Maertens, Johan A; Manz, Markus G; ... (2023). Prospective Validation of the Prognostic Relevance of CD34+CD38- AML Stem Cell frequency in the HOVON-SAKK132 trial. Blood, 141(21), pp. 2657-2661. American Society of Hematology 10.1182/blood.2022019160
Gillich, Cédric; Akhoundova, Dilara; Hayoz, Michael; Aebi, Yolanda; Largiadèr, Carlo R; Seipel, Katja; Daskalakis, Michael; Bacher, Vera; Pabst, Thomas (2023). Efficacy and Safety of High-Dose Chemotherapy with Treosulfan and Melphalan in Multiple Myeloma. Cancers, 15(10) MDPI AG 10.3390/cancers15102699
von Matt, Stefanie; Bacher, Ulrike; Banz, Yara; Mansouri Taleghani, Behrouz; Novak, Urban; Pabst, Thomas (2023). Outcome of Patients with Diffuse Large B-Cell Lymphoma Relapsing after Autologous Transplant before Availability of CAR-T Cell Treatment. Mediterranean journal of hematology and infectious diseases, 15(1), e2023025. Università Cattolica del Sacro Cuore 10.4084/MJHID.2023.025
Akhoundova Sanoyan, Dilara; Seipel, Katja; Bacher, Ulrike; Kronig, Marie-Noelle; Porret, Naomi; Wiedemann, Gertrud; Daskalakis, Michael; Pabst, Thomas (2023). Real-life experiences with CAR T-cell therapy with idecabtagene vicleucel (ide-cel) for triple-class exposed relapsed/refractory multiple myeloma patients. BMC cancer, 23(1), p. 345. BioMed Central 10.1186/s12885-023-10824-3
Huwyler, Fabrizio; Kunz, Rebekka; Bacher, Ulrike; Hoffmann, Michèle; Novak, Urban; Daskalakis, Michael; Banz, Yara; Pabst, Thomas (2023). Evaluation of Bortezomib-BeEAM (2BeEAM) as Chemotherapy Regimen Prior to ASCT in Patients with Mantle Cell Lymphoma. Cancers, 15(7) MDPI AG 10.3390/cancers15072091
Heini, Alexander D; Beck, Philipp; Bacher, Ulrike; Seipel, Katja; Zander, Thilo; Daskalakis, Michael; Pabst, Thomas (2023). BeEAM Conditioning including High-Dose Bendamustine before Autologous Stem Cell Transplantation Is Safe and Effective in Patients with Waldenstrom's Macroglobulinemia. Journal of Clinical Medicine, 12(6) MDPI 10.3390/jcm12062378
Wittibschlager, Valerie; Bacher, Ulrike; Seipel, Katja; Porret, Naomi; Wiedemann, Gertrud; Haslebacher, Claudia; Hoffmann, Michèle; Daskalakis, Michael; Akhoundova, Dilara; Pabst, Thomas (2023). CAR T-Cell Persistence Correlates with Improved Outcome in Patients with B-Cell Lymphoma. International journal of molecular sciences, 24(6) MDPI 10.3390/ijms24065688
Zander, Thilo; Pabst, Thomas; Schär, Sämi; Aebi, Stefan; Mey, Ulrich; Novak, Urban; Lerch, Erika; Rhyner Agocs, Gaëlle; Goede, Jeroen; Maniecka, Zuzanna; Hayoz, Stefanie; Rüfer, Axel; Renner, Christoph; Driessen, Christoph (2023). Alternate-day dosing of pomalidomide in relapsed/ refractory multiple myeloma: a multicenter, single-arm phase 2 trial. Leukemia, 37(3), pp. 699-701. Springer Nature 10.1038/s41375-023-01809-z
Lakomy, Tim; Akhoundova, Dilara; Nilius, Henning; Kronig, Marie-Noëlle; Novak, Urban; Daskalakis, Michael; Bacher, Ulrike; Pabst, Thomas (2023). Early Use of Corticosteroids following CAR T-Cell Therapy Correlates with Reduced Risk of High-Grade CRS without Negative Impact on Neurotoxicity or Treatment Outcome. Biomolecules, 13(2) MDPI 10.3390/biom13020382
Bühler, Selina; Akhoundova, Dilara; Jeker, Barbara; Legros, Myriam; Seipel, Katja; Daskalakis, Michael; Bacher, Ulrike; Pabst, Thomas (2023). Stem Cell Mobilization with Ixazomib and G-CSF in Patients with Multiple Myeloma. Cancers, 15(2) MDPI AG 10.3390/cancers15020430
Bohler, Jeanne; Bacher, Ulrike; Banz, Yara; Stadelmann, Raphael; Medinger, Michael; Zander, Thilo; Pabst, Thomas (2023). Blinatumomab in Relapsed/Refractory Burkitt Lymphoma. Cancers, 15(1), p. 44. MDPI AG 10.3390/cancers15010044
Beyeler, Morin; Grunder, Lorenz; Göcmen, Jayan; Steinauer, Fabienne; Belachew, Nebiyat F; Kielkopf, Moritz; Clénin, Leander; Mueller, Madlaine; Silimon, Norbert; Kurmann, Christoph; Meinel, Thomas; Bücke, Philipp; Seiffge, David Julian; Dobrocky, Tomas; Piechowiak, Eike I; Pilgram-Pastor, Sara; Mattle, Heinrich P; Navi, Babak B; Arnold, Marcel; Fischer, Urs; ... (2023). Absence of susceptibility vessel sign and hyperdense vessel sign in patients with cancer-related stroke. Frontiers in neurology, 14(1148152), p. 1148152. Frontiers Media S.A. 10.3389/fneur.2023.1148152
Beyeler, Morin; Castigliego, Pasquale; Baumann, Joel; Ziegler, Victor; Kielkopf, Moritz; Mueller, Madlaine; Bauer-Gambelli, Stefan A; Mujanovic, Adnan; Meinel, Thomas; Horvath, Thomas; Fischer, Urs; Kaesmacher, Johannes; Heldner, Mirjam R; Seiffge, David; Arnold, Marcel; Pabst, Thomas; Berger, Martin D; Navi, Babak B; Jung, Simon and Bücke, Philipp (2023). Transient ischemic attacks in patients with active and occult cancer. Frontiers in neurology, 14(1268131), p. 1268131. Frontiers Media S.A. 10.3389/fneur.2023.1268131
Seipel, Katja; Frey, Michèle; Nilius, Henning; Akhoundova, Dilara; Banz, Yara; Bacher, Ulrike; Pabst, Thomas (2023). Low-Frequency PPM1D Gene Mutations Affect Treatment Response to CD19-Targeted CAR T-Cell Therapy in Large B-Cell Lymphoma. Current oncology, 30(12), pp. 10463-10476. MDPI 10.3390/curroncol30120762
Qiu, Peiyong; Pabst, Thomas (2023). Characterization of particle size segregation and heterogeneity along the slopes of a waste rock pile using image analysis. Environmental Earth Science, 82(23), p. 573. Springer 10.1007/s12665-023-11229-y
Rüegsegger, Laura; Schanz, Urs; Seipel, Katja; Pabst, Thomas; Schwegler, Jürg; Schmidt, Elisabeth; Schmidt, Adrian (2022). Emberger Syndrome – A Family History Over 3 Generations (In Press). Healthbook TIMES oncology hematology, 14(4), pp. 34-40. The Healthbook Company 10.36000/hbT.OH.2022.14.092
Seipel, Katja; Brügger, Yvo; Mandhair, Harpreet; Bacher, Ulrike; Pabst, Thomas (2022). Rationale for Combining the BCL2 Inhibitor Venetoclax with the PI3K Inhibitor Bimiralisib in the Treatment of IDH2- and FLT3-Mutated Acute Myeloid Leukemia. International journal of molecular sciences, 23(20) MDPI 10.3390/ijms232012587
Rebmann Chigrinova, Ekaterina; Porret, Naomi A; Andres, Martin; Wiedemann, Gertrud; Banz, Yara; Legros, Myriam; Pollak, Matthias; Oppliger Leibundgut, Elisabeth; Pabst, Thomas; Bacher, Ulrike (2022). Correlation of plasma cell assessment by phenotypic methods and molecular profiles by NGS in patients with plasma cell dyscrasias. BMC medical genomics, 15(1), p. 203. BioMed Central 10.1186/s12920-022-01346-1
Rausch, Christian; Bacher, Ulrike; Rabaglio, Manuela; Vorburger, Corinne; Klingenberg, Anke; Banz, Yara; Daskalakis, Michael; Pabst, Thomas (2022). Combining BeEAM with Brentuximab Vedotin for High-Dose Therapy in CD30 Positive Lymphomas before Autologous Transplantation-A Phase I Study. Journal of clinical medicine, 11(18) MDPI 10.3390/jcm11185378
Heini, Alexander D; Bacher, Ulrike; Porret, Naomi; Wiedemann, Gertrud; Legros, Myriam; Stalder Zeerleder, Denise; Seipel, Katja; Novak, Urban; Daskalakis, Michael; Pabst, Thomas (2022). Experiences with Glofitamab Administration following CAR T Therapy in Patients with Relapsed Mantle Cell Lymphoma. Cells, 11(17) MDPI 10.3390/cells11172747
Gössi, Simona; Bacher, Ulrike; Haslebacher, Claudia; Nagler, Michael; Suter, Franziska; Staehelin, Cornelia; Novak, Urban; Pabst, Thomas (2022). Humoral Responses to Repetitive Doses of COVID-19 mRNA Vaccines in Patients with CAR-T-Cell Therapy. Cancers, 14(14) MDPI AG 10.3390/cancers14143527
Stoffel, Tanja; Bacher, Ulrike; Banz, Yara; Daskalakis, Michael; Novak, Urban; Pabst, Thomas (2022). BeEAM High-Dose Chemotherapy with Polatuzumab (Pola-BeEAM) before ASCT in Patients with DLBCL-A Pilot Study. Journal of clinical medicine, 11(13) MDPI 10.3390/jcm11133748
Beyeler, Morin; Birner, Barbara; Branca, Mattia; Meinel, Thomas; Vynckier, Jan; Buffle, Eric; Scutelnic, Adrian; Heldner, Mirjam R; Bücke, Philipp; Seiffge, David; Mordasini, Pascale; Dobrocky, Tomas; Piechowiak, Eike I; Kaesmacher, Johannes; Gralla, Jan; Mattle, Heinrich P; Arnold, Marcel; Fischer, Urs; Pabst, Thomas; Berger, Martin D; ... (2022). Development of a score for prediction of occult malignancy in stroke patients (occult-5 score). Journal of stroke and cerebrovascular diseases, 31(8), p. 106609. Elsevier 10.1016/j.jstrokecerebrovasdis.2022.106609
Heini, Alexander D; Bacher, Ulrike; Kronig, Marie-Noëlle; Wiedemann, Gertrud; Novak, Urban; Zeerleder, Sacha; Mansouri Taleghani, Behrouz; Daskalakis, Michael; Pabst, Thomas (2022). Chimeric antigen receptor T-cell therapy for relapsed mantle cell lymphoma: real-world experience from a single tertiary care center. Bone marrow transplantation, 57(6), pp. 1010-1012. Springer Nature 10.1038/s41409-022-01658-x
Farag, Sarah; Bacher, Ulrike; Jeker, Barbara; Legros, Myriam; Rhyner, Gaelle; Lüthi, Jean-Marc; Schardt, Julian; Zander, Thilo; Daskalakis, Michael; Mansouri, Behrouz; Manz, Chantal; Pabst, Thomas (2022). Adding bendamustine to melphalan before ASCT improves CR rate in myeloma vs. melphalan alone: A randomized phase-2 trial. Bone marrow transplantation, 57(6), pp. 990-997. Springer Nature 10.1038/s41409-022-01681-y
Rentsch, Vera; Seipel, Katja; Banz, Yara; Wiedemann, Gertrud; Porret, Naomi; Bacher, Ulrike; Pabst, Thomas (2022). Glofitamab Treatment in Relapsed or Refractory DLBCL after CAR T-Cell Therapy. Cancers, 14(10) MDPI AG 10.3390/cancers14102516
Linnik, Janina; Syedbasha, Mohammedyaseen; Kaltenbach, Hans-Michael; Vogt, Dominik; Hollenstein, Yvonne; Kaufmann, Lukas; Cantoni, Nathan; Ruosch-Girsberger, Sabine; Müller, Antonia M S; Schanz, Urs; Pabst, Thomas; Stüssi, Georg; Weisser, Maja; Halter, Jörg; Stelling, Jörg; Egli, Adrian (2022). Association of Host Factors With Antibody Response to Seasonal Influenza Vaccination in Allogeneic Hematopoietic Stem Cell Transplant Patients. The journal of infectious diseases, 225(8), pp. 1482-1493. Oxford University Press 10.1093/infdis/jiab391
Grob, Tim; Al Hinai, Adil S A; Sanders, Mathijs A; Kavelaars, François G; Rijken, Melissa; Gradowska, Patrycja L; Biemond, Bart J; Breems, Dimitri A; Maertens, Johan; van Marwijk Kooy, Marinus; Pabst, Thomas; de Weerdt, Okke; Ossenkoppele, Gert J; van de Loosdrecht, Arjan A; Huls, Gerwin A; Cornelissen, Jan J; Beverloo, H Berna; Löwenberg, Bob; Jongen-Lavrencic, Mojca and Valk, Peter J M (2022). Molecular characterization of mutant TP53 acute myeloid leukemia and high-risk myelodysplastic syndrome. Blood, 139(15), pp. 2347-2354. American Society of Hematology 10.1182/blood.2021014472
Mathys, Anina; Bacher, Ulrike; Banz, Yara; Legros, Myriam; Mansouri Taleghani, Behrouz; Novak, Urban; Pabst, Thomas (2022). Outcome of patients with mantle cell lymphoma after autologous stem cell transplantation in the pre-CAR T-cell era Letter. Hematological oncology, 40(2), pp. 292-296. Wiley 10.1002/hon.2952
Kreissl, Stefanie; Voltin, Conrad‐Amadeus; Kaul, Helen; Bühnen, Ina; Mettler, Jasmin; Pabst, Thomas; Eichenauer, Dennis A.; Fuchs, Michael; Diehl, Volker; Dietlein, Markus; Engert, Andreas; Borchmann, Peter; Kobe, Carsten (2022). Impact of bone marrow involvement on early positron emission tomography response and progression‐free survival in the HD18 trial for patients with advanced‐stage Hodgkin lymphoma. British journal of haematology, 197(1), e5-e8. Wiley-Blackwell 10.1111/bjh.17997
Seipel, Katja; Porret, Naomi; Wiedemann, Gertrud; Jeker, Barbara; Bacher, Vera Ulrike; Pabst, Thomas (2022). sBCMA Plasma Level Dynamics and Anti-BCMA CAR-T-Cell Treatment in Relapsed Multiple Myeloma. Current issues in molecular biology, 44(4), pp. 1463-1471. MDPI 10.3390/cimb44040098
Gurevich, Ekaterina; Hayoz, Michael; Aebi, Yolanda; Largiadèr, Carlo R; Mansouri Taleghani, Behrouz; Bacher, Ulrike; Pabst, Thomas (2022). Comparison of Melphalan Combined with Treosulfan or Busulfan as High-Dose Chemotherapy before Autologous Stem Cell Transplantation in AML. Cancers, 14(4) MDPI AG 10.3390/cancers14041024
Shumilov, Evgenii; Shakhanova, Inna; Flach, Johanna; Schmidt, Nicole; Buerki, Susanne; Legros, Myriam; Kronig, Marie-Noëlle; Ofran, Yishai; Gerull, Sabine; Medinger, Michael; Mansouri Taleghani, Behrouz; Passweg, Jakob; Halter, Jörg; Bacher, Ulrike; Pabst, Thomas (2022). Feasibility and efficacy of salvage allogeneic stem cell transplantation in AML patients relapsing after autologous stem cell transplantation. Bone marrow transplantation, 57(2), pp. 224-231. Springer Nature 10.1038/s41409-021-01521-5
Bakunina, Katerina; Putter, Hein; Versluis, Jurjen; Koster, Eva A S; van der Holt, Bronno; Manz, Markus G; Breems, Dimitri A; Gjertsen, Bjorn T; Cloos, Jacqueline; Valk, Peter J M; Passweg, Jakob; Pabst, Thomas; Ossenkoppele, Gert J; Löwenberg, Bob; Cornelissen, Jan J; de Wreede, Liesbeth C (2022). The added value of multi-state modelling in a randomized controlled trial: The HOVON 102 study re-analyzed. Cancer medicine, 11(3), pp. 630-640. Wiley 10.1002/cam4.4392
Shumilov, Evgenii; Mazzeo, Paolo; Zinkernagel, Martin S.; Legros, Myriam; Porret, Naomi; Romagna, Lorenz; Haase, Detlef; Lenz, Georg; Novak, Urban; Banz, Yara; Pabst, Thomas; Bacher, Vera (2022). Comprehensive Laboratory Diagnostic Workup for Patients with Suspected Intraocular Lymphoma including Flow Cytometry, Molecular Genetics and Cytopathology. Current oncology, 29(2), pp. 766-776. MDPI 10.3390/curroncol29020065
Heidemeier, Anke; Thurner, Annette; Metz, Corona; Pabst, Thomas; Heidemeier, Heike; Rasche, Leo; Kortüm, K Martin; Einsele, Hermann; Grimm, Robert; Weiland, Elisabeth; Bley, Thorsten Alexander (2022). Whole-Body MRI with an Ultrahigh b-Value of 2000 s/mm2 Improves the Specificity of Diffusion-Weighted Imaging in Patients with Plasma Cell Dyscrasias. Academic radiology, 29(1), e1-e8. Elsevier 10.1016/j.acra.2020.09.016
Tettero, Jesse M; Al-Badri, Waleed K W; Ngai, Lok Lam; Bachas, Costa; Breems, Dimitri A; van Elssen, Catharina H M J; Fischer, Thomas; Gjertsen, Bjorn T; van Gorkom, Gwendolyn N Y; Gradowska, Patrycja; Greuter, Marjolein J E; Griskevicius, Laimonas; Juliusson, Gunnar; Maertens, Johan; Manz, Markus G; Pabst, Thomas; Passweg, Jakob; Porkka, Kimmo; Löwenberg, Bob; Ossenkoppele, Gert J; ... (2022). Concordance in measurable residual disease result after first and second induction cycle in acute myeloid leukemia: An outcome- and cost-analysis. Frontiers in oncology, 12, p. 999822. Frontiers Research Foundation 10.3389/fonc.2022.999822
Messmer, Anna S; Que, Yok-Ai; Schankin, Christoph; Banz, Yara; Bacher, Ulrike; Novak, Urban; Pabst, Thomas (2021). CAR T-cell therapy and critical care : A survival guide for medical emergency teams. Wiener klinische Wochenschrift, 133(23-24), pp. 1318-1325. Springer-Verlag 10.1007/s00508-021-01948-2
Condoluci, Adalgisa; Théaudin, Marie; Schwotzer, Rahel; Pazhenkottil, Aju P; Arosio, Paolo; Averaimo, Manuela; Bacher, Ulrike; Bode, Peter; Cavalli, Andrea; Dirnhofer, Stefan; Djerbi, Nadia; Dobner, Stephan; Fehr, Thomas; Garofalo, Maura; Gaspert, Ariana; Gerull, Sabine; Heimgartner, Raphael; Hübers, Annemarie; Jung, Hans H; Kessler, Chiara; ... (2021). Management of transthyretin amyloidosis. Swiss medical weekly, 151(w30053), w30053. EMH Media 10.4414/smw.2021.w30053
Messmer, Anna Sarah; Que, Yok-Ai; Schankin, Christoph; Banz, Yara; Bacher, Ulrike; Novak, Urban; Pabst, Thomas (2021). Novel Adaptive T-Cell Oncological Treatments Lead to New Challenges for Medical Emergency Teams: A 2-Year Experience From a Tertiary-Care Hospital in Switzerland. Critical care explorations, 3(10), e0552. Wolters Kluwer Health 10.1097/CCE.0000000000000552
Damonti, Lauro; Buetti, Niccolò; Droz, Sara; Bacher, Ulrike; Pabst, Thomas; Mansouri Taleghani, Behrouz; Baerlocher, Gabriela Maria; Marschall, Jonas (2021). Prevalence and significance of bacterial contamination of autologous stem cell products. The journal of hospital infection, 114, pp. 175-179. Elsevier 10.1016/j.jhin.2021.04.006
Stamm, Simone Lena; Spichiger, Elisabeth; Pabst, Thomas; Bachnick, Stefanie; Jeitziner, Marie-Madlen (2021). Symptom prevalence and health-related quality of life in patients undergoing autologous stem cell transplantation - A longitudinal observational study. European journal of oncology nursing, 53, p. 101997. Elsevier 10.1016/j.ejon.2021.101997
Peter, Raffaele; Halter, Joerg P; Heim, Dominik; Medinger, Michael; Pabst, Thomas; Stussi, Georg; Passweg, Jakob R; Gerull, Sabine (2021). Lack of association of travel time to transplant center and posttransplant care model with outcome parameters after allogeneic transplantation. Bone marrow transplantation, 56(8), pp. 2024-2026. Springer Nature 10.1038/s41409-021-01301-1
Seipel, Katja; Graber, Carolyn; Flückiger, Laura; Bacher, Vera; Pabst, Thomas (2021). Rationale for a Combination Therapy with the STAT5 Inhibitor AC-4-130 and the MCL1 Inhibitor S63845 in the Treatment of FLT3-Mutated or TET2-Mutated Acute Myeloid Leukemia. International journal of molecular sciences, 22(15) MDPI 10.3390/ijms22158092
Heini, Alexander D.; Porret, Naomi; Zenhaeusern, Reinhard; Winkler, Annette; Bacher, Ulrike; Pabst, Thomas (2021). Clonal Hematopoiesis after Autologous Stem Cell Transplantation Does Not Confer Adverse Prognosis in Patients with AML. Cancers, 13(13) MDPI AG 10.3390/cancers13133190
Kreissl, Stefanie; Goergen, Helen; Buehnen, Ina; Kobe, Carsten; Moccia, Alden; Greil, Richard; Eichenauer, Dennis A; Zijlstra, Josée M; Markova, Jana; Meissner, Julia; Feuring-Buske, Michaela; Soekler, Martin; Beck, Hans-Joachim; Willenbacher, Wolfgang; Ludwig, Wolf-Dieter; Pabst, Thomas; Topp, Max S; Hitz, Felicitas; Bentz, Martin; Keller, Ulrich Bernd; ... (2021). PET-guided eBEACOPP treatment of advanced-stage Hodgkin lymphoma (HD18): follow-up analysis of an international, open-label, randomised, phase 3 trial. The Lancet. Haematology, 8(6), e398-e409. Elsevier 10.1016/S2352-3026(21)00101-0
Brune, Magdalena M; Stüssi, Georg; Lundberg, Pontus; Vela, Visar; Heim, Dominik; Manz, Markus G; Haralambieva, Eugenia; Pabst, Thomas; Banz, Yara; Bargetzi, Mario; Grobholz, Rainer; Fehr, Martin; Cogliatti, Sergio; Ossenkoppele, Gert J; Löwenberg, Bob; Rudolf, Christina Biaggi; Li, Qiyu; Passweg, Jakob; Mazzuchelli, Luca; Medinger, Michael; ... (2021). Effects of lenalidomide on the bone marrow microenvironment in acute myeloid leukemia: Translational analysis of the HOVON103 AML/SAKK30/10 Swiss trial cohort. Annals of hematology, 100(5), pp. 1169-1179. Springer-Verlag 10.1007/s00277-021-04467-2
Moret, Fabienne; Marschall, Jonas; Atkinson, Andrew; Farag, Sarah; Zimmerli, Stefan; Pabst, Thomas; Sommerstein, Rami (2021). Characteristics of respiratory virus infections in autologous hematopoietic stem cell transplantation patients, a prospective study, Bern, Switzerland, 2015-2017. Infectious diseases, 53(4), pp. 274-280. Taylor & Francis 10.1080/23744235.2021.1871642
Pabst, Thomas; Bacher, Ulrike (2021). Risk stratification systems for allogeneic haematopoietic stem-cell transplantation. The Lancet. Haematology, 8(3), e166-e167. Elsevier 10.1016/S2352-3026(20)30403-8
Löwenberg, Bob; Pabst, Thomas; Maertens, Johan; Gradowska, Patrycja; Biemond, Bart J; Spertini, Olivier; Vellenga, Edo; Griskevicius, Laimonas; Tick, Lidwine W; Jongen-Lavrencic, Mojca; van Marwijk Kooy, Marinus; Vekemans, Marie-Christiane; van der Velden, Walter J F M; Beverloo, Berna; Michaux, Lucienne; Graux, Carlos; Deeren, Dries; de Weerdt, Okke; van Esser, Joost W J; Bargetzi, Mario; ... (2021). Addition of lenalidomide to intensive treatment in younger and middle-aged adults with newly diagnosed AML: the HOVON-SAKK-132 trial. Blood advances, 5(4), pp. 1110-1121. American Society of Hematology 10.1182/bloodadvances.2020003855
Janssen, Jeroen; Löwenberg, Bob; Manz, Markus; Bargetzi, Mario; Biemond, Bart; Borne, Peter von dem; Breems, Dimitri; Brouwer, Rolf; Chalandon, Yves; Deeren, Dries; Efthymiou, Anna; Gjertsen, Bjørn-Tore; Graux, Carlos; Gregor, Michael; Heim, Dominik; Hess, Urs; Hoogendoorn, Mels; Jaspers, Aurelie; Jie, Asiong; Jongen-Lavrencic, Mojca; ... (2021). Inferior Outcome of Addition of the Aminopeptidase Inhibitor Tosedostat to Standard Intensive Treatment for Elderly Patients with AML and High Risk MDS. Cancers, 13(4) MDPI AG 10.3390/cancers13040672
Seipel, Katja; Kopp, Basil; Bacher, Ulrike; Pabst, Thomas (2021). BMI1-Inhibitor PTC596 in Combination with MCL1 Inhibitor S63845 or MEK Inhibitor Trametinib in the Treatment of Acute Leukemia. Cancers, 13(3) MDPI AG 10.3390/cancers13030581
Betticher, Christophe; Bacher, Ulrike; Legros, Myriam; Zimmerli, Stefan; Banz, Yara; Mansouri Taleghani, Behrouz; Pabst, Thomas (2021). Prophylactic corticosteroid use prevents engraftment syndrome in patients after autologous stem cell transplantation. Hematological oncology, 39(1), pp. 97-104. Wiley 10.1002/hon.2813
Borchmann, Peter; Plütschow, Annette; Kobe, Carsten; Greil, Richard; Meissner, Julia; Topp, Max S; Ostermann, Helmut; Dierlamm, Judith; Mohm, Johannes; Thiemer, Julia; Sökler, Martin; Kerkhoff, Andrea; Ahlborn, Miriam; Halbsguth, Teresa V; Martin, Sonja; Keller, Ulrich; Balabanov, Stefan; Pabst, Thomas; Vogelhuber, Martin; Hüttmann, Andreas; ... (2021). PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17): a multicentre, open-label, randomised, phase 3 trial. The lancet oncology, 22(2), pp. 223-234. Elsevier 10.1016/S1470-2045(20)30601-X
Bröckelmann, Paul J; Müller, Horst; Guhl, Teresa; Behringer, Karolin; Fuchs, Michael; Moccia, Alden A; Rank, Andreas; Soekler, Martin; Vieler, Tom; Pabst, Thomas; Baues, Christian; von Tresckow, Bastian; Borchmann, Peter; Engert, Andreas (2021). Relapse After Early-Stage, Favorable Hodgkin Lymphoma: Disease Characteristics and Outcomes With Conventional or High-Dose Chemotherapy. Journal of clinical oncology, 39(2), pp. 107-115. American Society of Clinical Oncology 10.1200/JCO.20.00947
Brechbühl, Simon; Bacher, Ulrike; Jeker, Barbara; Pabst, Thomas (2021). Real-World Outcome in the pre-CAR-T Era of Myeloma Patients Qualifying for CAR-T Cell Therapy. Mediterranean journal of hematology and infectious diseases, 13(1), e2021012. Università Cattolica del Sacro Cuore 10.4084/MJHID.2021.012
Nydegger, Anna; Novak, Urban; Kronig, Marie-Noëlle; Legros, Myriam; Zeerleder, Sacha; Banz, Yara; Bacher, Ulrike; Pabst, Thomas (2021). Transformed Lymphoma Is Associated with a Favorable Response to CAR-T-Cell Treatment in DLBCL Patients. Cancers, 13(23) MDPI AG 10.3390/cancers13236073
Zander, Thilo; Pabst, Thomas; Schär, Sämi; Aebi, Stefan; Pabst, Tobias; Mey, Ulrich; Novak, Urban; Lerch, Erika; Rhyner, Gaëlle; Goede, Jeroen; Maniecka, Zuzanna; Hayoz, Stefanie; Rufer, Axel; Renner, Christoph; Driessen, Christoph (2021). P-227: Alternate day dosing of pomalidomide in patients with refractory/relapsed multiple myeloma (RRMM): Results of a multicenter, single arm phase 2 trial (SAKK 39/16 OptiPOM Study). Clinical lymphoma, myeloma and leukemia, 21(Suppl. 2), S165-S165. Elsevier 10.1016/S2152-2650(21)02354-5
Moccia, Alden A; Taverna, Christian; Schär, Sämi; Vanazzi, Anna; Rondeau, Stéphanie; Hitz, Felicitas; Mingrone, Walter; Pabst, Thomas; Cevreska, Lidija; Del Giglio, Auro; Raats, Johann; Rauch, Daniel; Vorobiof, Daniel A; Lohri, Andreas; Ruegsegger, Céline; Biaggi Rudolf, Christine; Rusterholz, Corinne; Hayoz, Stefanie; Ghielmini, Michele and Zucca, Emanuele (2020). Prolonged rituximab maintenance in follicular lymphoma patients: long-term results of the SAKK 35/03 randomized trial. Blood advances, 4(23), pp. 5951-5957. American Society of Hematology 10.1182/bloodadvances.2020002858
Averbuch, Diana; Tridello, Gloria; Hoek, Jennifer; Mikulska, Malgorzata; Pabst, Thomas; Yaňez San Segundo, Lucrecia; Akan, Hamdi; Özçelik, Tülay; Donnini, Irene; Klyasova, Galina; Botelho de Sousa, Aida; Zuckerman, Tsila; Tecchio, Cristina; de la Camara, Rafael; Aki, Sahika Zeynep; Ljungman, Per; Gülbas, Zafer; Nicolas-Virelizier, Emmanuelle; Calore, Elisabetta; Perruccio, Katia; ... (2020). Intercontinental study on pre-engraftment and post-engraftment Gram-negative rods bacteremia in hematopoietic stem cell transplantation patients: Risk factors and association with mortality. Journal of infection, 81(6), pp. 882-894. Elsevier 10.1016/j.jinf.2020.11.002
Schwotzer, Rahel; Flammer, Andreas J; Gerull, Sabine; Pabst, Thomas; Arosio, Paolo; Averaimo, Manuela; Bacher, Vera; Bode, Peter; Cavalli, Andrea; Concoluci, Adalgisa; Dirnhofer, Stefan; Djerbi, Nadia; Dobner, Stephan W.; Fehr, Thomas; Garofalo, Maura; Gaspert, Ariana; Heimgartner, Raphael; Hübers, Annemarie; Jung, Hans H; Kessler, Chiara; ... (2020). Expert recommendation from the Swiss Amyloidosis Network (SAN) for systemic AL-amyloidosis. Swiss medical weekly, 150(w20364), w20364. EMH Media 10.4414/smw.2020.20364
Idle, Jeffrey R; Seipel, Katja; Bacher, Ulrike; Pabst, Thomas; Beyoğlu, Diren (2020). (2R,3S)-Dihydroxybutanoic Acid Synthesis as a Novel Metabolic Function of Mutant Isocitrate Dehydrogenase 1 and 2 in Acute Myeloid Leukemia. Cancers, 12(10) MDPI AG 10.3390/cancers12102842
Waitz, Markus; Engel, Corinna; Schloesser, Rolf; Rochwalsky, Ulrich; Meyer, Sascha; Larsen, Alexander; Hoffmann, Paul; Zemlin, Michael; Bohnhorst, Bettina; Peter, Corinna; Hoppenz, Marc; Pabst, Thomas; Zimmer, Klaus-Peter; Franz, Axel R; Haertel, Christoph; Frieauff, Eric; Sandkötter, Julia; Masjosthusmann, Katja; Deindl, Philipp; Singer, Dominique; ... (2020). Application of two different nasal CPAP levels for the treatment of respiratory distress syndrome in preterm infants-"The OPTTIMMAL-Trial"-Optimizing PEEP To The IMMAture Lungs: study protocol of a randomized controlled trial. Trials, 21(1), p. 822. BioMed Central 10.1186/s13063-020-04660-0
Jeker, Barbara; Farag, Sarah; Mansouri Taleghani, Behrouz; Novak, Urban; Mueller, Beatrice U; Li, Qiyu; Betticher, Daniel; Luethi, Jean-Marc; Farese, Simone; Ruefer, Axel; Bacher, Ulrike; Pabst, Thomas (2020). A randomized evaluation of vinorelbine versus gemcitabine chemotherapy mobilization of stem cells in myeloma patients. Bone marrow transplantation, 55(10), pp. 2047-2051. Springer Nature 10.1038/s41409-020-0875-8
Flach, Johanna; Shumilov, Evgenii; Wiedemann, Gertrud; Porret, Naomi; Shakhanova, Inna; Bürki, Susanne; Legros, Myriam; Joncourt, Raphael; Pabst, Thomas; Bacher, Ulrike (2020). Clinical potential of introducing next-generation sequencing in patients at relapse of acute myeloid leukemia. Hematological oncology, 38(4), pp. 425-431. Wiley 10.1002/hon.2739
Eicher, Florian; Mansouri Taleghani, Behrouz; Schild, Christof; Bacher, Vera; Pabst, Thomas (2020). Reduced survival after autologous stem cell transplantation in myeloma and lymphoma patients with low vitamin D serum levels. Hematological oncology, 38(4), pp. 523-530. Wiley 10.1002/hon.2774
Huls, Gerwin; Chitu, Dana A; Pabst, Thomas; Klein, Saskia K; Stussi, Georg; Griskevicius, Laimonas; Valk, Peter J M; Cloos, Jacqueline; van de Loosdrecht, Arjan A; Breems, Dimitri; van Lammeren-Venema, Danielle; van Zeventer, Isabelle; Boersma, Rinske; Jongen-Lavrencic, Mojca; Fehr, Martin; Hoogendoorn, Mels; Manz, Markus G; Söhne, Maaike; van Marwijk Kooy, Rien; Deeren, Dries; ... (2020). Ibrutinib added to 10-day decitabine for older patients with AML and higher risk MDS. Blood advances, 4(18), pp. 4267-4277. American Society of Hematology 10.1182/bloodadvances.2020002846
Colucci, Giuseppe; Pabst, Thomas; Bacher, Ullrike; Maggioli, Caterina; Zecca, Chiara; Gobbi, Claudio (2020). A case of CIDP concurrent with MGUS IgG kappa responsive to autologous stem cell transplantation. Neurology: Neuroimmunology and Neuroinflammation, 7(6) Wolters Kluwer Health 10.1212/NXI.0000000000000888
Riether, Carsten; Pabst, Thomas; Höpner, Sabine; Bacher, Ulrike; Hinterbrandner, Magdalena; Banz, Yara; Müller, Rouven; Manz, Markus G.; Gharib, Walid H.; Francisco, David; Bruggmann, Remy; van Rompaey, Luc; Moshir, Mahan; Delahaye, Tim; Gandini, Domenica; Erzeel, Ellen; Hultberg, Anna; Fung, Samson; de Haard, Hans; Leupin, Nicolas; ... (2020). Targeting CD70 with cusatuzumab eliminates acute myeloid leukemia stem cells in patients treated with hypomethylating agents. Nature medicine, 26(9), pp. 1459-1467. Springer Nature 10.1038/s41591-020-0910-8
Benz, Rudolf; Arn, Kornelius; Andres, Martin; Pabst, Thomas; Baumann, Michael; Novak, Urban; Hitz, Felicitas; Hess, Urs; Zenhaeusern, Reinhard; Chalandon, Yves; Mey, Ulrich; Blum, Sabine; Rauch, Daniel; O'Meara Stern, Alix; Cantoni, Nathan; Bargetzi, Mario; Bianchi-Papina, Elena; Rossi, Davide; Passweg, Jakob; Lohri, Andreas; ... (2020). Prospective long-term follow-up after first-line subcutaneous cladribine in hairy cell leukemia: a SAKK trial. Blood advances, 4(15), pp. 3699-3707. American Society of Hematology 10.1182/bloodadvances.2020002160
Fagnan, Alexandre; Bagger, Frederik Otzen; Piqué-Borràs, Maria-Riera; Ignacimouttou, Cathy; Caulier, Alexis; Lopez, Cécile K; Robert, Elie; Uzan, Benjamin; Gelsi-Boyer, Véronique; Aid, Zakia; Thirant, Cécile; Moll, Ute; Tauchmann, Samantha; Kurtovic-Kozaric, Amina; Maciejewski, Jaroslaw; Dierks, Christine; Spinelli, Orietta; Salmoiraghi, Silvia; Pabst, Thomas; Shimoda, Kazuya; ... (2020). Human erythroleukemia genetics and transcriptomes identify master transcription factors as functional disease drivers. Blood, 136(6), pp. 698-714. American Society of Hematology 10.1182/blood.2019003062
Sula, Martin; Bacher, Vera; Oppliger Leibundgut, Elisabeth; Mansouri, Behrouz; Novak, Urban; Pabst, Thomas (2020). Excellent outcome after consolidation with autologous transplantation in patients with core binding factor acute myeloid leukemia. Bone marrow transplantation, 55(8), pp. 1690-1693. Springer Nature 10.1038/s41409-019-0762-3
Pabst, Thomas; Joncourt, Raphael; Shumilov, Evgenii; Heini, Alexander; Wiedemann, Gertrud; Legros, Myriam; Seipel, Katja; Schild, Christof; Jalowiec, Katarzyna; Mansouri, Behrouz; Fux, Michaela; Novak, Urban; Porret, Naomi; Zeerleder, Sacha; Bacher, Vera (2020). Analysis of IL-6 serum levels and CAR-T cell specific digital PCR in the context of cytokine release syndrome (CRS). Experimental hematology, 88, 7-14.e3. Elsevier 10.1016/j.exphem.2020.07.003
Orvain, Corentin; Balsat, Marie; Tavernier, Emmanuelle; Marolleau, Jean-Pierre; Pabst, Thomas; Chevallier, Patrice; de Gunzburg, Noémie; Cacheux, Victoria; Huguet, Françoise; Chantepie, Sylvain; Caillot, Denis; Chalandon, Yves; Frayfer, Jamilé; Bonmati, Caroline; Lheritier, Véronique; Ifrah, Norbert; Dombret, Hervé; Boissel, Nicolas; Hunault-Berger, Mathilde (2020). Thromboembolism prophylaxis in adult patients with acute lymphoblastic leukemia treated in the GRAALL-2005 study. Blood, 136(3), pp. 328-338. American Society of Hematology 10.1182/blood.2020004919
Flach, Johanna; Shumilov, Evgenii; Joncourt, Raphael; Porret, Naomi; Novak, Urban; Pabst, Thomas; Bacher, Ulrike (2020). Current concepts and future directions for hemato-oncologic diagnostics. Critical reviews in oncology, hematology, 151, p. 102977. Elsevier 10.1016/j.critrevonc.2020.102977
Flach, Johanna; Shumilov, Evgenii; Joncourt, Raphael; Porret, Naomi; Tchinda, Joëlle; Legros, Myriam; Scarpelli, Ilaria; Hewer, Ekkehard; Novak, Urban; Schoumans, Jacqueline; Bacher, Vera; Pabst, Thomas (2020). Detection of rare reciprocal RUNX1 rearrangements by next‐generation sequencing (NGS) in acute myeloid leukemia. Genes, chromosomes & cancer, 59(4), pp. 268-274. Wiley 10.1002/gcc.22829
Passweg, J R; Labopin, M; Christopeit, M; Cornelissen, J; Pabst, Thomas; Socié, G; Russel, N; Yakoub-Agha, I; Blaise, D; Gedde-Dahl, T; Labussière-Wallet, H; Malladi, R; Forcade, E; Maury, S; Polge, E; Lanza, F; Gorin, N C; Mohty, M; Nagler, A (2020). Post remission consolidation by autologous HCT for AML in CR1, negative implications for subsequent allogeneic HCT in CR2. A Study by the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT). Biology of blood and marrow transplantation, 26(4), pp. 659-664. Elsevier 10.1016/j.bbmt.2019.11.021
Heini, Alexander D.; Hugo, Rebecca; Berger, Martin D.; Novak, Urban; Bacher, Ulrike; Pabst, Thomas (2020). A simple acute phase protein score to predict long-term survival in patients with acute myeloid leukemia. Hematological oncology, 38(1), pp. 74-81. Wiley 10.1002/hon.2696
Seipel, Katja; Messerli, Christian; Wiedemann, Gertrud; Bacher, Ulrike; Pabst, Thomas (2020). MN1, FOXP1 and hsa-miR-181a-5p as prognostic markers in acute myeloid leukemia patients treated with intensive induction chemotherapy and autologous stem cell transplantation. Leukemia research, 89(106296), p. 106296. Elsevier 10.1016/j.leukres.2020.106296
Rindlisbacher, Barbara; Schild, Christof; Egger, Florence; Bacher, Vera U.; Pabst, Thomas; Leichtle, Alexander; Andres, Martin; Sédille-Mostafaie, Nazanin (2020). Serum Free Light Chain Assay: Shift Toward a Higher κ/λ Ratio. The journal of applied laboratory medicine, 5(1), pp. 114-125. Oxford University Press 10.1093/jalm.2019.029330
De Santiago de Benito, Alvaro; Jeker, Barbara; Gfeller, Eva; Porret, Naomi; Banz, Yara; Novak, Urban; Bacher, Ulrike; Pabst, Thomas (2020). Molecular minimal residual disease negativity and decreased stem cell mobilization potential predict excellent outcome after autologous transplant in NPM1 mutant acute myeloid leukemia. Haematologica - the hematology journal, 105(1), e9-e12. Ferrata-Storti Foundation 10.3324/haematol.2019.216457
Flach, Johanna; Shumilov, Evgenii; Porret, Naomi; Shakhanova, Inna; Legros, Myriam; Kronig, Marie-Noëlle; Joncourt, Raphael; Bacher, Ulrike; Pabst, Thomas (2020). Experiences with Next-Generation Sequencing in Relapsed Acute Myeloid Leukemia: A Patient Case Series. Mediterranean journal of hematology and infectious diseases, 12(1), e2020068. Università Cattolica del Sacro Cuore 10.4084/MJHID.2020.068
Messikommer, Alessandra; Seipel, Katja; Byrne, Stephen; Valk, Peter J. M.; Pabst, Thomas; Luedtke, Nathan W. (2020). RNA Targeting in Acute Myeloid Leukemia. ACS pharmacology & translational science, 3(6), pp. 1225-1232. ACS Publications 10.1021/acsptsci.0c00120
Moser, Sebastian; Bacher, Vera Ulrike; Jeker, Barbara; Mansouri Taleghani, Behrouz; Betticher, Daniel; Ruefer, Axel; Egger, Thomas; Novak, Urban; Pabst, Thomas (2019). Autologous stem cell transfusions on multiple days in patients with multiple myeloma ‐ does it matter? Hematological oncology, 37(5), pp. 649-651. Wiley 10.1002/hon.2673
Shumilov, Evgenii; Flach, Johanna; Joncourt, Raphael; Porret, Naomi; Wiedemann, Gertrud; Novak, Urban; Gfeller, Eva; Jeker, Barbara; Amstutz, Ursula; Pabst, Thomas; Bacher, Vera (2019). Clinical value of molecular MRD monitoring by next-generation sequencing in patients with IDH2 mutated AML. Leukemia & lymphoma, 60(10), pp. 2588-2590. Taylor & Francis 10.1080/10428194.2019.1585838
Engelbrecht, Laura; Götze, Katharina; Schwamborn, Kristina; Müller-Thomas, Catharina; Alpermann, Tamara; Bonadies, Nicolas; Legros, Myriam; Flach, Johanna; Pabst, Thomas; Banz, Yara; Bacher, Vera (2019). Correlation of cytomorphology and histopathology in the diagnostic process of myeloid malignancies. Hematology & medical oncology OAT 10.15761/HMO.1000190
Angelillo-Scherrer, Anne; Mansouri Taleghani, Behrouz; Förger, Frauke; Baerlocher, Gabriela M.; Pabst, Thomas; Pöllinger, Alexander; Banz, Yara; Geiser, Thomas; Kremer Hovinga, Johanna A.; Rovó, Alicia (2019). Immunoadsorption and autologous transplantation for life-threatening primary antiphospholipid syndrome. Blood advances, 3(17), pp. 2664-2667. American Society of Hematology 10.1182/bloodadvances.2019000465
Hitz, F; Kraus, M; Pabst, Thomas; Hess, D; Besse, L; Silzle, T; Novak, Urban; Seipel, Katja; Rondeau, S; Stüdeli, S; Vilei, S Berardi; Samaras, P; Mey, U; Driessen, C (2019). Nelfinavir and lenalidomide/dexamethasone in patients with lenalidomide-refractory multiple myeloma. A phase I/II Trial (SAKK 39/10). Blood cancer journal, 9(9), p. 70. Springer Nature 10.1038/s41408-019-0228-2
Karow, Axel; Wilhelm, Anna; Ammann, Roland R.; Baerlocher, Gabriela M.; Pabst, Thomas; Mansouri Taleghani, Behrouz; Rössler, Jochen Karl; Leibundgut, Kurt (2019). Peripheral blood progenitor cell collection in pediatric patients optimized by high pre-apheresis count of circulating CD34+ cells and high blood flow. Bone marrow transplantation, 54(6), pp. 885-893. Nature Publishing Group 10.1038/s41409-018-0353-8
Jent, Philipp; Thalmann, Laura; Pabst, Thomas; Droz, Sara; Sendi, Parham (2019). Adjunctive gentamicin did not improve outcome of enterococcal bacteraemia in neutropenic patients: a propensity scored matched study. Infectious diseases, 51(6), pp. 409-416. Taylor & Francis 10.1080/23744235.2019.1581946
Samaras, Panagiotis; Bargetzi, Mario; Betticher, Daniel C; Driessen, Christoph; Duchosal, Michel A; Heim, Dominik; Ketterer, Nicolas; Lerch, Erika; Matthes, Thomas; Mey, Ulrich; Pabst, Thomas; Schmidt, Adrian; Taverna, Christian; Zander, Thilo; Renner, Christoph (2019). Updated recommendations for diagnosis and treatment of plasma cell myeloma in Switzerland. Swiss medical weekly, 2019(149), pp. 1-8. EMH Media 10.4414/smw.2019.20031
Amsler, Isabel G; Jeker, Barbara; Mansouri Taleghani, Behrouz; Bacher, Ulrike; Betticher, Daniel; Egger, Thomas; Zander, Thilo; Luethi, Jean-Marc; Novak, Urban; Pabst, Thomas (2019). Prolonged survival with increasing duration of lenalidomide maintenance after autologous transplant for multiple myeloma. Leukemia & lymphoma, 60(2), pp. 511-514. Taylor & Francis 10.1080/10428194.2018.1473577
Shumilov, Evgenii; Flach, Johanna; Joncourt, Raphael; Porret, Naomi; Wiedemann, Gertrud; Angelillo, Anne; Trümper, Lorenz; Fiedler, Georg Martin; Jeker, Barbara; Amstutz, Ursula; Pabst, Thomas; Bacher, Vera (2019). Critical evaluation of current molecular MRD strategies including NGS for the management of AML patients with multiple mutations. Hematological oncology, 37(3), pp. 319-322. Wiley 10.1002/hon.2603
Shumilov, Evgenyi; Novak, Urban; Jeker, Barbara; Mansouri Taleghani, Behrouz; Bacher, Ulrike; Pabst, Thomas (2019). Hematopoietic Stem Cell Mobilization With Plerixafor Is Safe and Effective in Poorly Mobilizing Acute Myeloid Leukemia Patients. HemaSphere, 3(2), e176. Wolters Kluwer Health 10.1097/HS9.0000000000000176
Schnell, Bianca R.; Seipel, Katja; Bacher, Ulrike; Jeker, Barbara; Mueller, Beatrice U.; Banz, Yara; Novak, Urban; Pabst, Thomas (2019). Rebound Thrombocytosis after Induction Chemotherapy is a Strong Biomarker for Favorable Outcome in AML Patients. HemaSphere, 3(2), e180. Wolters Kluwer Health 10.1097/HS9.0000000000000180
Moor, Ivana; Bacher, Vera Ulrike; Jeker, Barbara; Mansouri Taleghani, Behrouz; Mueller, Beatrice U; Keller, Heinz Peter; Betticher, Daniel; Egger, Thomas; Novak, Urban; Pabst, Thomas (2018). Peripheral flow-MRD status at the time of autologous stem cell collection predicts outcome in multiple myeloma. Bone marrow transplantation, 53(12), pp. 1599-1602. Nature Publishing Group 10.1038/s41409-018-0245-y
Bacher, Vera Ulrike; Shumilov, Evgenii; Flach, Johanna; Porret, Naomi; Joncourt, Raphael; Wiedemann, Gertrud; Fiedler, Martin; Novak, Urban; Amstutz, Ursula; Pabst, Thomas (2018). Challenges in the introduction of next-generation sequencing (NGS) for diagnostics of myeloid malignancies into clinical routine use. Blood cancer journal, 8(11), p. 113. Nature Publishing Group 10.1038/s41408-018-0148-6
Shumilov, Evgenii; Flach, Johanna; Kohlmann, Alexander; Banz Wälti, Yara; Bonadies, Nicolas; Fiedler, Martin; Pabst, Thomas; Bacher, Ulrike (2018). Current status and trends in the diagnostics of AML and MDS. Blood reviews, 32(6), pp. 508-519. Elsevier 10.1016/j.blre.2018.04.008
Bacher, Vera Ulrike; Porret, Naomi; Joncourt, Raphael; Sanz, Javier; Aliu, Nijas; Wiedemann, Gertrud; Jeker, Barbara; Banz Wälti, Yara; Pabst, Thomas (2018). Pitfalls in the molecular follow up of mutant acute myeloid leukemia. Haematologica - the hematology journal, 103(10), e486-e488. Ferrata-Storti Foundation 10.3324/haematol.2018.192104
Alva, Laura C; Bacher, Vera Ulrike; Seipel, Katja; Mansouri Taleghani, Behrouz; Mueller, Beatrice U; Novak, Urban; Pabst, Thomas (2018). Iron overload is correlated with impaired autologous stem cell mobilization and survival in acute myeloid leukemia. Transfusion, 58(10), pp. 2365-2373. Wiley-Blackwell 10.1111/trf.14895
Köffel, René; Wolfmeier, Heidi Annemarie; Larpin, Yu Noël; Besançon, Hervé; Schönauer, Roman; Babiychuk, Victoria; Drücker, Patrick; Pabst, Thomas; Mitchell, TJ; Babiychuk, Eduard; Draeger, Annette (2018). Host-Derived Microvesicles Carrying Bacterial Pore-Forming Toxins Deliver Signals to Macrophages: A Novel Mechanism of Shaping Immune Responses. Frontiers in immunology, 9(1688), p. 1688. Frontiers Research Foundation 10.3389/fimmu.2018.01688
D'Alitto, Felicia; Scherz, Amina; Margini, Cristina; von Tengg-Kobligk, Hendrik; Montani, Matteo; Pabst, Thomas; Berzigotti, Annalisa (2018). Portal Hypertension and a Stiff Liver. Cureus, 10(6), e2768. 10.7759/cureus.2768
Gössi, Ursina; Jeker, Barbara; Mansouri Taleghani, Behrouz; Bacher, Vera Ulrike; Novak, Urban; Betticher, Daniel; Egger, Thomas; Zander, Thilo; Pabst, Thomas (2018). Prolonged survival after second autologous transplantation and lenalidomide maintenance for salvage treatment of myeloma patients at first relapse after prior autograft. Hematological oncology, 36(2), pp. 436-444. Wiley 10.1002/hon.2490
Jeker, Barbara; Novak, Urban; Mansouri Taleghani, Behrouz; Baerlocher, Gabriela M.; Seipel, K; Mueller, B U; Bigler, M; Betticher, D; Luethi, J-M; Farese, S; Ruefer, A; Pabst, Thomas (2018). NSAID treatment with meloxicam enhances peripheral stem cell mobilization in myeloma. Bone marrow transplantation, 53(2), pp. 175-179. Nature Publishing Group 10.1038/bmt.2017.234
Schlenk, Richard F; Krauter, Jürgen; Raffoux, Emmanuel; Kreuzer, Karl-Anton; Schaich, Markus; Noens, Lucien; Pabst, Thomas; Vusirikala, Madhuri; Bouscary, Didier; Spencer, Andrew; Candoni, Anna; Gil, Jorge Sierra; Berkowitz, Noah; Weber, Hans-Jochen; Ottmann, Oliver (2018). Panobinostat monotherapy and combination therapy in patients with acute myeloid leukemia: results from two clinical trials. Haematologica - the hematology journal, 103(1), e25-e28. Ferrata-Storti Foundation 10.3324/haematol.2017.172411
Passweg, Jakob R; Baldomero, Helen; Ansari, Marc; Baerlocher, Gabriela M.; Bargetzi, Mario; Chalandon, Yves; Duchosal, Michel A; Gerull, Sabine; Güngör, Tayfun; Halter, Jörg P; Heim, Dominik; Hess, Urs; Leibundgut, Kurt; Masouridi-Levrat, Stavroula; Müller, Antonia; Nair, Gayathri; Pabst, Thomas; Renner, Christoph; Schmidt, Adrian; Stussi, Georg; ... (2018). Haematopoietic cell transplantation in Switzerland, changes and results over 20 years: a report from the Swiss Blood Stem Cell Transplantation Working Group for Blood and Marrow Transplantation registry 1997-2016. Swiss medical weekly, 148(w14589), w14589. EMH Schweizerischer Ärzteverlag 10.4414/smw.2018.14589
Mueller, Beatrice; Seipel, Katja; Bacher, Vera Ulrike; Pabst, Thomas (2018). Autologous Transplantation for Older Adults with AML. Cancers, 10(9), p. 340. MDPI AG 10.3390/cancers10090340
Berger, Martin Dave; Heini, Alexander D; Seipel, Katja; Mueller, Beatrice; Angelillo-Scherrer, Anne; Pabst, Thomas (2017). Increased fibrinogen levels at diagnosis are associated with adverse outcome in patients with acute myeloid leukemia. Hematological oncology, 35(4), pp. 789-796. Wiley 10.1002/hon.2307
Voegeli, Michèle; Rondeau, Stephanie; Berardi Vilei, Simona; Lerch, Erika; Wannesson, Luciano; Pabst, Thomas; Rentschler, Jochen; Bargetzi, Mario; Jost, Lorenz; Ketterer, Nicolas; Bischof Delaloye, Angelika; Ghielmini, Michele (2017). Y(90) -Ibritumomab tiuxetan (Y(90) -IT) and high-dose melphalan as conditioning regimen before autologous stem cell transplantation for elderly patients with lymphoma in relapse or resistant to chemotherapy: a feasibility trial (SAKK 37/05). Hematological oncology, 35(4), pp. 576-583. Wiley 10.1002/hon.2348
Gorin, Norbert-Claude; Labopin, Myriam; Pabst, Thomas; Remenyi, Peter; Wu, Depei; Huynh, Anne; Volin, Liisa; Cahn, Jean Yves; Yakoub-Agha, Ibrahim; Mercier, Melanie; Houhou, Mohamed; Mohty, Mohamad; Nagler, Arnon (2017). Unrelated matched versus autologous transplantation in adult patients with good and intermediate risk acute myelogenous leukemia in first molecular remission. American journal of hematology, 92(12), pp. 1318-1323. Wiley-Liss 10.1002/ajh.24904
Averbuch, Diana; Tridello, Gloria; Hoek, Jennifer; Mikulska, Malgorzata; Akan, Hamdi; Yanez San Segundo, Lucrecia; Pabst, Thomas; Özçelik, Tülay; Klyasova, Galina; Donnini, Irene; Wu, Depei; Gülbas, Zafer; Zuckerman, Tsila; Botelho de Sousa, Aida; Beguin, Yves; Xhaard, Aliénor; Bachy, Emmanuel; Ljungman, Per; de la Camara, Rafael; Rascon, Jelena; ... (2017). Antimicrobial Resistance in Gram-Negative Rods Causing Bacteremia in Hematopoietic Stem Cell Transplant Recipients: Intercontinental Prospective Study of the Infectious Diseases Working Party of the European Bone Marrow Transplantation Group. Clinical infectious diseases, 65(11), pp. 1819-1828. Oxford University Press 10.1093/cid/cix646
Metzelder, S K; Schroeder, T; Lübbert, M; Ditschkowski, M; Götze, K; Scholl, S; Meyer, R G; Dreger, P; Basara, N; Fey, Martin; Salih, H R; Finck, A; Pabst, Thomas; Giagounidis, A; Kobbe, G; Wollmer, E; Finke, J; Neubauer, A; Burchert, A (2017). Long-term survival of sorafenib-treated FLT3-ITD-positive acute myeloid leukaemia patients relapsing after allogeneic stem cell transplantation. European journal of cancer, 86, pp. 233-239. Elsevier 10.1016/j.ejca.2017.09.016
Versluis, Jurjen; Kalin, Burak; Zeijlemaker, Wendelien; Passweg, Jakob; Graux, Carlos; Manz, Markus G; Vekemans, Marie-Christiane; Biemond, Bart J; Legdeur, Marie-Cecile J C; Kooy, Marinus van Marwijk; de Weerdt, Okke; Wijermans, Pierre W; Hoogendoorn, Mels; Bargetzi, Mario J; Kuball, Juergen; Schouten, Harry C; van der Velden, Vincent H J; Janssen, Jeroen J W M; Pabst, Thomas; Lowenberg, Bob; ... (2017). Graft-Versus-Leukemia Effect of Allogeneic Stem-Cell Transplantation and Minimal Residual Disease in Patients With Acute Myeloid Leukemia in First Complete Remission. JCO precision oncology, 1, pp. 1-13. American Society of Clinical Oncology 10.1200/PO.17.00078
Ribi, Karin; Rondeau, Stéphanie; Hitz, Felicitas; Mey, Ulrich; Enoiu, Milica; Pabst, Thomas; Stathis, Anastasios; Fischer, Natalie; Clough-Gorr, Kerri M (2017). Cancer-specific geriatric assessment and quality of life: important factors in caring for older patients with aggressive B-cell lymphoma. Supportive care in cancer, 25(9), pp. 2833-2842. Springer 10.1007/s00520-017-3698-4
Pabst, Thomas; Kortz, Linda; Fiedler, Georg Martin; Ceglarek, Uta; Idle, Jeffrey; Beyoglu, Diren (2017). The plasma lipidome in acute myeloid leukemia at diagnosis in relation to clinical disease features. BBA clinical, 7, pp. 105-114. Elsevier 10.1016/j.bbacli.2017.03.002
Blum, Veronika; Heini, A D; Novak, Urban; Mansouri Taleghani, Behrouz; Baerlocher, Gabriela M.; Leibundgut, Kurt; Seipel, K; Banz Wälti, Yara; Bargetzi, M; Pabst, Thomas (2017). Hematopoietic stem cell remobilization with vinorelbine and filgrastim in AML. Bone marrow transplantation, 52(5), pp. 786-788. Nature Publishing Group 10.1038/bmt.2017.2
Oberson, JS; Novak, Urban; Mansouri Taleghani, Behrouz; Baerlocher, Gabriela M.; Seipel, Katja; Mueller, BU; Leibundgut, Kurt; Zimmerli, Stefan; Pabst, Thomas (2017). Revisiting G-CSF Support for Hematologic Recovery after Autologous Transplantation in AML Patients. Annals of Hematology & Oncology, 4(5), p. 1148. Austin Publishing Group 10.26420/annhematoloncol.2017.1148
Meissner, J; Finel, H; Dietrich, S; Boumendil, A; Kanfer, E; Laboure, G; Abecasis, M; Cornelissen, J; Delage, J; Finke, J; Hess, U; Ludwig, H; Mohty, M; Pabst, Thomas; Pioltelli, P; Robinson, S; Samaras, P; Montoto, S; Dreger, P (2017). Autologous hematopoietic stem cell transplantation for intravascular large B-cell lymphoma: the European Society for Blood and Marrow Transplantation experience. Bone marrow transplantation, 52(4), pp. 650-652. Nature Publishing Group 10.1038/bmt.2016.339
Löwenberg, Bob; Pabst, Thomas; Maertens, Johan; van Norden, Yvette; Biemond, Bart J; Schouten, Harry C; Spertini, Olivier; Vellenga, Edo; Graux, Carlos; Havelange, Violaine; de Greef, Georgine E; de Weerdt, Okke; Legdeur, Marie-Cecile J C; Kuball, Juergen; Kooy, Marinus van Marwijk; Gjertsen, Bjorn T; Jongen-Lavrencic, Mojca; van de Loosdrecht, Arjan A; van Lammeren-Venema, Daniëlle; Hodossy, Beata; ... (2017). Therapeutic value of clofarabine in younger and middle-aged (18-65 years) adults with newly diagnosed AML. Blood, 129(12), pp. 1636-1645. American Society of Hematology 10.1182/blood-2016-10-740613
Gorin, Norbert-Claude; Labopin, Myriam; Czerw, Tomasz; Pabst, Thomas; Blaise, Didier; Dumas, Pierre-Yves; Nemet, Damir; Arcese, William; Trisolini, Silvia Maria; Wu, Depei; Huynh, Anne; Zuckerman, Tsila; Meijer, Ellen; Cagirgan, Seckin; Cornelissen, Jan; Houhou, Mohamed; Polge, Emmanuelle; Mohty, Mohamad; Nagler, Arnon (2017). Autologous stem cell transplantation for adult acute myelocytic leukemia in first remission-Better outcomes after busulfan and melphalan compared with busulfan and cyclophosphamide: A retrospective study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT). Cancer, 123(5), pp. 824-831. John Wiley & Sons 10.1002/cncr.30400
Baumgartner, Annic; Bargetzi, Mario; Bargetzi, Annika; Zueger, Noemi; Medinger, Micheal; Passweg, Jakob; Schanz, Urs; Samaras, Panagiotis; Chalandon, Yves; Pichard, Claude; Limonta, Alessandro; Wannesson, Luciano; Pabst, Thomas; Duchosal, Michel A; Hess, Urs; Stanga, Zeno; Mueller, Beat; Schuetz, Philipp (2017). Nutritional support practices in hematopoietic stem cell transplantation centers: A nationwide comparison. Nutrition, 35, pp. 43-50. Elsevier 10.1016/j.nut.2016.10.007
Heini, Alexander D; Berger, Martin Dave; Seipel, Katja; Mansouri Taleghani, Behrouz; Baerlocher, Gabriela M.; Leibundgut, Kurt; Banz Wälti, Yara; Novak, Urban; Pabst, Thomas (2017). Consolidation with autologous stem cell transplantation in first remission is safe and effective in AML patients above 65 years. Leukemia research, 53, pp. 28-34. Elsevier 10.1016/j.leukres.2016.12.001
Gössi, F; Spahn, Martin; Zweifel, Martin; Panagiotis, S; Mischo, A; Stenner, F; Hess, U; Berthold, D; Bargetzi, M; Schardt, Julian; Pabst, Thomas (2017). Comparison of three or fewer high-dose chemotherapy cycles as salvage treatment in germ cell tumors in first relapse. Bone marrow transplantation, 52(2), pp. 334-336. Nature Publishing Group 10.1038/bmt.2016.285
Stettler, Jasmin; Novak, Urban; Baerlocher, Gabriela M.; Seipel, Katja; Mansouri Taleghani, Behrouz; Pabst, Thomas (2017). Autologous stem cell transplantation in elderly patients with multiple myeloma: evaluation of its safety and efficacy. Leukemia & lymphoma, 58(5), pp. 1076-1083. Informa Healthcare 10.1080/10428194.2016.1233542
Fridle, Chantal; Medinger, Michael; Wilk, Matthias C; Seipel, Katja; Passweg, Jakob; Manz, Markus G; Pabst, Thomas (2017). Cladribine, cytarabine and idarubicin (CLA-Ida) salvage chemotherapy in relapsed acute myeloid leukemia (AML). Leukemia & lymphoma, 58(5), pp. 1068-1075. Informa Healthcare 10.1080/10428194.2016.1235274
Versluis, J; In 't Hout, F E M; Devillier, R; van Putten, W L J; Manz, M G; Vekemans, M-C; Legdeur, M-C; Passweg, J R; Maertens, J; Kuball, J; Biemond, B J; Valk, P J M; van der Reijden, B A; Meloni, G; Schouten, H C; Vellenga, E; Pabst, Thomas; Willemze, R; Löwenberg, B; Ossenkoppele, G; ... (2017). Comparative value of post-remission treatment in cytogenetically normal AML subclassified by NPM1 and FLT3-ITD allelic ratio. Leukemia, 31(1), pp. 26-33. Nature Publishing Group 10.1038/leu.2016.183
Gilli, Stefanie; Novak, Urban; Mansouri Taleghani, Behrouz; Baerlocher, Gabriela M.; Leibundgut, Kurt; Banz Wälti, Yara; Zander, Thilo; Betticher, Daniel; Egger, Thomas; Rauch, Daniel; Pabst, Thomas (2017). BeEAM conditioning with bendamustine-replacing BCNU before autologous transplantation is safe and effective in lymphoma patients. Annals of hematology, 96(3), pp. 421-429. Springer 10.1007/s00277-016-2900-y
Riether, Carsten; Schürch, Christian M.; Bührer, Elias D.; Hinterbrandner, Magdalena; Huguenin, Anne-Laure; Höpner, Sabine; Zlobec, Inti; Pabst, Thomas; Radpour, Ramin; Ochsenbein, Adrian F. (2017). CD70/CD27 signaling promotes blast stemness and is a viable therapeutic target in acute myeloid leukemia. The Journal of experimental medicine, 214(2), pp. 359-380. Rockefeller Univ. Press 10.1084/jem.20152008
Steinrücken, Julia; Pabst, Thomas; Zimmerli, Stefan; Marschall, Jonas (2016). Low impact of urine cultures as a diagnostic tool in patients with neutropenic fever. Infectious diseases, 48(11-12), pp. 872-874. Taylor & Francis 10.1080/23744235.2016.1205216
Hitz, Felicitas; Zucca, Emanuele; Pabst, Thomas; Fischer, Natalie; Cairoli, Anne; Samaras, Panagiotis; Caspar, Clemens B; Mach, Nicolas; Krasniqi, Fatime; Schmidt, Adrian; Rothermundt, Christian; Enoiu, Milica; Eckhardt, Katrin; Berardi Vilei, Simona; Rondeau, Stephanie; Mey, Ulrich (2016). Rituximab, bendamustine and lenalidomide in patients with aggressive B-cell lymphoma not eligible for anthracycline-based therapy or intensive salvage chemotherapy - SAKK 38/08. British journal of haematology, 174(2), pp. 255-263. Wiley-Blackwell 10.1111/bjh.14049
Taverna, Christian; Martinelli, Giovanni; Hitz, Felicitas; Mingrone, Walter; Pabst, Thomas; Cevreska, Lidija; Del Giglio, Auro; Vanazzi, Anna; Laszlo, Daniele; Raats, Johann; Rauch, Daniel; Vorobiof, Daniel A; Lohri, Andreas; Biaggi Rudolf, Christine; Rondeau, Stéphanie; Rusterholz, Corinne; Heijnen, Ingmar A F M; Zucca, Emanuele; Ghielmini, Michele (2016). Rituximab Maintenance for a Maximum of 5 Years After Single-Agent Rituximab Induction in Follicular Lymphoma: Results of the Randomized Controlled Phase III Trial SAKK 35/03. Journal of clinical oncology, 34(5), pp. 495-500. American Society of Clinical Oncology 10.1200/JCO.2015.61.3968
Seipel, Katja; Marques, Miguel Teixera; Bozzini, Marie-Ange; Meinken, Christina; Mueller, Beatrice U; Pabst, Thomas (2016). Inactivation of the p53-KLF4-CEBPA Axis in Acute Myeloid Leukemia. Clinical cancer research, 22(3), pp. 746-756. American Association for Cancer Research 10.1158/1078-0432.CCR-15-1054
Berger, Martin Dave; Branger, Giacomo; Klaeser, Bernd; Mansouri Taleghani, Behrouz; Novak, Urban; Banz Wälti, Yara; Müller, Beatrice Ursula; Pabst, Thomas (2016). Zevalin and BEAM (Z-BEAM) versus rituximab and BEAM (R-BEAM) conditioning chemotherapy prior to autologous stem cell transplantation in patients with mantle cell lymphoma. Hematological oncology, 34(3), pp. 133-139. Wiley 10.1002/hon.2197
Pathak, Anand; Seipel, Katja; Pemov, Alexander; Dewan, Ramita; Brown, Christina; Ravichandran, Sarangan; Luke, Brian T; Malasky, Michael; Suman, Shalabh; Yeager, Meredith; Cancer GenomicsResearch Laboratory, Nci Dceg; Cancer Sequencing Working Group, Nci Dceg; Parry, Dilys M; Gatti, Richard A; Caporaso, Neil E; Mulvihill, John; Goldin, Lynn R; Pabst, Thomas; McMaster, Mary L and Stewart, Douglas R (2016). Whole-exome sequencing reveals a C-terminal germline variant in CEBPA-associated acute myeloid leukemia: 45-year follow-up of a large family. Haematologica - the hematology journal, 101(7), pp. 846-852. Ferrata-Storti Foundation 10.3324/haematol.2015.130799
Driessen, Christoph; Kraus, Marianne; Joerger, Markus; Rosing, Hilde; Bader, Jürgen; Hitz, Felicitas; Berset, Catherine; Xyrafas, Alexandros; Hawle, Hanne; Berthod, Gregoire; Overkleeft, Hermann S; Sessa, Cristiana; Huitema, Alwin; Pabst, Thomas; von Moos, Roger; Hess, Dagmar; Mey, Ulrich J M (2016). Treatment with the HIV protease inhibitor Nelfinavir triggers the unfolded protein response and may overcome proteasome inhibitor resistance of multiple myeloma in combination with bortezomib: a phase I trial (SAKK 65/08). Haematologica - the hematology journal, 101(3), pp. 346-355. Ferrata-Storti Foundation 10.3324/haematol.2015.135780
Mueller, Beatrice U; Keller, Sandra; Seipel, Katja; Mansouri Taleghani, Behrouz; Rauch, Daniel; Betticher, Daniel; Egger, Thomas; Pabst, Thomas (2015). Stem cell mobilization chemotherapy with gemcitabine is effective and safe in myeloma patients with bortezomib-induced neurotoxicity. Leukemia & lymphoma, 57(5), pp. 1122-1129. Informa Healthcare 10.3109/10428194.2015.1079315
Versluis, Jurjen; Hazenberg, Carin L E; Passweg, Jakob R; van Putten, Wim L J; Maertens, Johan; Biemond, Bart J; Theobald, Matthias; Graux, Carlos; Kuball, Jurgen; Schouten, Harry C; Pabst, Thomas; Löwenberg, Bob; Ossenkoppele, Gert; Vellenga, Edo; Cornelissen, Jan J (2015). Post-remission treatment with allogeneic stem cell transplantation in patients aged 60 years and older with acute myeloid leukaemia: a time-dependent analysis. The Lancet. Haematology, 2(10), e427-e436. Elsevier 10.1016/S2352-3026(15)00148-9
Walter, Roland B; Othus, Megan; Löwenberg, Bob; Ossenkoppele, Gert J; Petersdorf, Stephen H; Pabst, Thomas; Vekemans, Marie-Christiane; Appelbaum, Frederick R; Erba, Harry P; Estey, Elihu H (2015). Empiric definition of eligibility criteria for clinical trials in relapsed/refractory acute myeloid leukemia: analysis of 1,892 patients from HOVON/SAKK and SWOG. Haematologica - the hematology journal, 100(10), e409-e411. Ferrata-Storti Foundation 10.3324/haematol.2015.130013
Tawana, Kiran; Wang, Jun; Renneville, Aline; Bödör, Csaba; Hills, Robert; Loveday, Chey; Savic, Aleksandar; Van Delft, Frederik W; Treleaven, Jennifer; Georgiades, Panayiotis; Uglow, Elizabeth; Asou, Norio; Uike, Naokuni; Debeljak, Maruša; Jazbec, Janez; Ancliff, Philip; Gale, Rosemary; Thomas, Xavier; Mialou, Valerie; Döhner, Konstanze; ... (2015). Disease evolution and outcomes in familial AML with germline CEBPA mutations. Blood, 126(10), pp. 1214-1223. American Society of Hematology 10.1182/blood-2015-05-647172
Schardt, Julian; Keller, Manuela; Seipel, Katja; Pabst, Thomas (2015). Functional interplay of SP family members and nuclear factor Y is essential for transcriptional activation of the human Calreticulin gene. Biochimica et biophysica acta - gene regulatory mechanisms, 1849(9), pp. 1188-1197. Elsevier 10.1016/j.bbagrm.2015.07.003
Mamot, Christoph; Klingbiel, Dirk; Hitz, Felicitas; Renner, Christoph; Pabst, Thomas; Driessen, Christoph; Mey, Ulrich; Pless, Miklos; Bargetzi, Mario; Krasniqi, Fatime; Gigli, Federica; Hany, Thomas; Samarin, Andrei; Biaggi, Christine; Rusterholz, Corinne; Dirnhofer, Stephan; Zucca, Emanuele; Martinelli, Giovanni (2015). Final Results of a Prospective Evaluation of the Predictive Value of Interim Positron Emission Tomography in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP-14 (SAKK 38/07). Journal of clinical oncology, 33(23), pp. 2523-2529. American Society of Clinical Oncology 10.1200/JCO.2014.58.9846
Keller, Sandra; Seipel, Katja; Novak, Urban; Mueller, Beatrice U; Mansouri Taleghani, Behrouz; Leibundgut, Kurt; Pabst, Thomas (2015). Neurotoxicity of stem cell mobilization chemotherapy with vinorelbine in myeloma patients after bortezomib treatment. Leukemia research, 39(7), pp. 786-792. Elsevier 10.1016/j.leukres.2015.03.015
Berger, Martin Dave; Branger, Giacomo; Leibundgut, Kurt; Baerlocher, Gabriela M; Seipel, Katja; Mueller, Beatrice U; Gregor, Michael; Ruefer, Axel; Pabst, Thomas (2015). CD34+ selected versus unselected autologous stem cell transplantation in patients with advanced-stage mantle cell and diffuse large B-cell lymphoma. Leukemia research, 39(6), pp. 561-567. Elsevier 10.1016/j.leukres.2015.03.004
Kamber, C; Zimmerli, Stefan; Suter, Franziska Marta; Müller, Beatrice Ursula; Mansouri Taleghani, Behrouz; Betticher, Daniel; Zander, T; Pabst, Thomas (2015). Varicella zoster virus reactivation after autologous SCT is a frequent event and associated with favorable outcome in myeloma patients. Bone marrow transplantation, 50(4), pp. 573-578. Nature Publishing Group 10.1038/bmt.2014.290
Wetzel, Dana; Müller, Beatrice Ursula; Mansouri Taleghani, Behrouz; Baerlocher, Gabriela M.; Seipel, Katja; Leibundgut, Kurt; Pabst, Thomas (2015). Delayed Haematological recovery after autologous stem cell transplantation is associated with favourable outcome in acute myeloid leukaemia. British journal of haematology, 168(2), pp. 268-273. Wiley-Blackwell 10.1111/bjh.13118
Koechli, Valentin; Klaeser, Bernd; Banz Wälti, Yara; Müller, Beatrice Ursula; Pabst, Thomas (2015). Consolidation of first remission using radioimmunotherapy with yttrium-90-ibritumomab-tiuxetan in adult patients with Burkitt lymphoma. Leukemia research, 39(3), pp. 307-310. Elsevier 10.1016/j.leukres.2014.12.016
Cornelissen, J J; Versluis, J; Passweg, Jakob; van Putten, W L J; Manz, M G; Maertens, J; Beverloo, H B; Valk, P J M; van Marwijk Kooy, M; Wijermans, P W; Schaafsma, M R; Biemond, B J; Vekemans, M-C; Breems, D A; Verdonck, L F; Fey, Martin; Jongen-Lavrencic, M; Janssen, J J W M; Huls, G; Kuball, J; ... (2015). Comparative therapeutic value of post-remission approaches in patients with acute myeloid leukemia aged 40-60 years. Leukemia, 29(5), pp. 1041-1050. Nature Publishing Group 10.1038/leu.2014.332
Garg, Abhishek D; Galluzzi, Lorenzo; Apetoh, Lionel; Baert, Thais; Birge, Raymond B; Bravo-San Pedro, José Manuel; Breckpot, Karine; Brough, David; Chaurio, Ricardo; Cirone, Mara; Coosemans, An; Coulie, Pierre G; De Ruysscher, Dirk; Dini, Luciana; de Witte, Peter; Dudek-Peric, Aleksandra M; Faggioni, Alberto; Fucikova, Jitka; Gaipl, Udo S; Golab, Jakub; ... (2015). Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death. Frontiers in immunology, 6(588), p. 588. Frontiers Research Foundation 10.3389/fimmu.2015.00588
Samaras, Panagiotis; Bargetzi, Mario; Betticher, Daniel C; Duchosal, Michel A; Heim, Dominik; Hess, Urs; Ketterer, Nicolas; Lerch, Erika; Matthes, Thomas; Mey, Ulrich; Pabst, Thomas; Taverna, Christian; Zander, Thilo; Renner, Christoph (2015). Current status and updated recommendations for diagnosis and treatment of plasma cell myeloma in Switzerland. Swiss medical weekly, 145, w14100. EMH Schweizerischer Ärzteverlag 10.4414/smw.2015.14100
Voermans, Nicol C; Benveniste, Olivier; Minnema, Monique C; Lokhorst, Henk; Lammens, Martin; Meersseman, Wouter; Delforge, Michel; Kuntzer, Thierry; Novy, Jan; Pabst, Thomas; Bouhour, Françoise; Romero, Norma; Leblond, Veronique; Bergh, Peter van den; Vekemans, Marie-Christiane; Engelen, Baziel G van; Eymard, Bruno (2014). Sporadic late-onset nemaline myopathy with MGUS: long-term follow-up after melphalan and SCT. Neurology, 83(23), pp. 2133-2139. Lippincott Williams & Wilkins 10.1212/WNL.0000000000001047
Morris, Curly; de Wreede, Liesbeth; Scholten, Marijke; Brand, Ronald; van Biezen, Anja; Sureda, Anna; Dickmeiss, Ebbe; Trneny, Marek; Apperley, Jane; Chiusolo, Patrizia; van Imhoff, Gustaaf W; Lenhoff, Stig; Martinelli, Giovanni; Hentrich, Marcus; Pabst, Thomas; Onida, Francesco; Quinn, Michael; Kroger, Nicolaus; de Witte, Theo and Ruutu, Tapani (2014). Should the standard dimethyl sulfoxide concentration be reduced? Results of a European Group for Blood and Marrow Transplantation prospective noninterventional study on usage and side effects of dimethyl sulfoxide. Transfusion, 54(10), pp. 2514-2522. Wiley-Blackwell 10.1111/trf.12759
Walter, R B; Othus, M; Burnett, A K; Löwenberg, B; Kantarjian, H M; Ossenkoppele, G J; Hills, R K; Ravandi, F; Pabst, Thomas; Evans, A; Pierce, S R; Vekemans, M-C; Appelbaum, F R; Estey, E H (2014). Resistance prediction in AML: analysis of 4601 patients from MRC/NCRI, HOVON/SAKK, SWOG and MD Anderson Cancer Center. Leukemia, 29(2), pp. 312-320. Nature Publishing Group 10.1038/leu.2014.242
Terwijn, Monique; Zeijlemaker, Wendelien; Kelder, Angèle; Rutten, Arjo P; Snel, Alexander N; Scholten, Willemijn J; Pabst, Thomas; Verhoef, Gregor; Löwenberg, Bob; Zweegman, Sonja; Ossenkoppele, Gert J; Schuurhuis, Gerrit J (2014). Leukemic stem cell frequency: a strong biomarker for clinical outcome in acute myeloid leukemia. PLoS ONE, 9(9), e107587. Public Library of Science 10.1371/journal.pone.0107587
Schmid, Andrea; Friess, Dorothea; Mansouri Taleghani, Behrouz; Keller, Peter; Müller, Beatrice Ursula; Baerlocher, Gabriela M.; Leibundgut, Kurt; Pabst, Thomas (2014). Role of plerixafor in autologous stem cell mobilization with vinorelbine chemotherapy and granulocyte-colony stimulating factor in patients with myeloma: a phase II study (PAV-trial). Leukemia & lymphoma, 56(3), pp. 608-614. Informa Healthcare 10.3109/10428194.2014.927454
Jegerlehner, Sabrina; Rothenbühler, Simon Paul; Pabst, Thomas (2014). Vision impairment at diagnosis of cancer - choroidal metastasis. Praxis - schweizerische Rundschau für Medizin, 103(11), pp. 641-647. Huber 10.1024/1661-8157/a001671
Raschle, Joëlle; Banz Wälti, Yara; Suter, Thomas; Pabst, Thomas (2014). A single-centre cohort of patients with systemic light chain AL-amyloidosis treated with conventional chemotherapy or with high-dose chemotherapy and autologous stem cell transplantation. Swiss medical weekly, 144, w13922. EMH Schweizerischer Ärzteverlag 10.4414/smw.2014.13922
Berger, Martin D.; Banz, Yara; Pabst, Thomas (2013). Pitfalls in the diagnosis of intravascular large B-cell lymphoma. European journal of haematology, 91(6), pp. 563-564. Wiley-Blackwell 10.1111/ejh.12162
Gutbrodt, K. L.; Schliemann, C.; Giovannoni, L.; Frey, K.; Pabst, Thomas; Klapper, W.; Berdel, W. E.; Neri, D. (2013). Antibody-Based Delivery of Interleukin-2 to Neovasculature Has Potent Activity Against Acute Myeloid Leukemia. Science translational medicine, 5(201), 201ra118-201ra118. American Association for the Advancement of Science 10.1126/scitranslmed.3006221
Schlenk, R. F.; Taskesen, E.; van Norden, Y.; Krauter, J.; Ganser, A.; Bullinger, L.; Gaidzik, V. I.; Paschka, P.; Corbacioglu, A.; Gohring, G.; Kundgen, A.; Held, G.; Gotze, K.; Vellenga, E.; Kuball, J.; Schanz, U.; Passweg, J.; Pabst, Thomas; Maertens, J.; Ossenkoppele, G. J.; ... (2013). The value of allogeneic and autologous hematopoietic stem cell transplantation in prognostically favorable acute myeloid leukemia with double mutant CEBPA. Blood, 122(9), pp. 1576-1582. American Society of Hematology 10.1182/blood-2013-05-503847
Passweg, Jakob R.; Pabst, Thomas; Blum, Sabine; Bargetzi, Mario; Li, Qiyu; Heim, Dominik; Stussi, Georg; Gregor, Michael; Leoncini, Leda; Meyer-Monard, Sandrine; Brauchli, Peter; Chalandon, Yves; Swiss Group for Clinical Cancer Research, SAKK (2013). Azacytidine for acute myeloid leukemia in elderly or frail patients: A phase II trial (SAKK 30/07). Leukemia & lymphoma, 55(1), pp. 87-91. London: Informa Healthcare 10.3109/10428194.2013.790540
Passweg, Jakob R; Baldomero, Helen; Bargetzi, Mario; Bucher, Christoph; Chalandon, Yves; Duchosal, Michel A; Gratwohl, Alois; Güngör, Tayfun; Hess, Urs; Leibundgut, Kurt; de Faveri, Grazia Nicoloso; Ozsahin, Hulya; Pabst, Thomas; Renner, Christoph; Stern, Martin; Stussi, Georg; Schanz, Urs; SBST (Swiss Blood Stem Cell Transplantation Group), (2013). Haematopoietic stem cell transplantation: activity in Switzerland compared with surrounding European countries. Swiss medical weekly, 143, w13757. Muttenz: EMH Schweizerischer Ärzteverlag
Neubauer, Henning; Pabst, Thomas; Dick, Anke; Machann, Wolfram; Evangelista, Laura; Wirth, Clemens; Köstler, Herbert; Hahn, Dietbert; Beer, Meinrad (2013). Small-bowel MRI in children and young adults with Crohn disease: retrospective head-to-head comparison of contrast-enhanced and diffusion-weighted MRI. Pediatric radiology, 43(1), pp. 103-14. Berlin: Springer 10.1007/s00247-012-2492-1
Gröschel, Stefan; Schlenk, Richard F; Engelmann, Jan; Rockova, Veronika; Teleanu, Veronica; Kühn, Michael W M; Eiwen, Karina; Erpelinck, Claudia; Havermans, Marije; Lübbert, Michael; Germing, Ulrich; Schmidt-Wolf, Ingo G H; Beverloo, H Berna; Schuurhuis, Gerrit J; Ossenkoppele, Gert J; Schlegelberger, Brigitte; Verdonck, Leo F; Vellenga, Edo; Verhoef, Gregor; Vandenberghe, Peter; ... (2013). Deregulated expression of EVI1 defines a poor prognostic subset of MLL-rearranged acute myeloid leukemias: a study of the German-Austrian Acute Myeloid Leukemia Study Group and the Dutch-Belgian-Swiss HOVON/SAKK Cooperative Group. Journal of clinical oncology, 31(1), pp. 95-103. Alexandria, Va.: American Society of Clinical Oncology 10.1200/JCO.2011.41.5505
Wannesson, Luciano; Bargetzi, Mario; Cairoli, Anne; Cerutti, Alessandra; Heim, Dominik; Hess, Urs; Lerch, Erika; Pabst, Thomas; Renner, Christoph; Samaras, Panagiotis; Zucca, Emanuele (2013). Autotransplant for Hodgkin lymphoma after failure of upfront BEACOPP escalated (bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine and prednisone). Leukemia & lymphoma, 54(1), pp. 36-40. London: Informa Healthcare 10.3109/10428194.2012.702903
Bükki, Johannes; Stanga, Zeno; Buitrago Tellez, Firouzeh; Duclos, Kathleen; Kolev, Mirjam; Krähenmann, Peter; Pabst, Thomas; Iff, Samuel; Jüni, Peter (2013). Omega-3 poly-unsaturated fatty acids for the prevention of severe neutropenic enterocolitis in patients with acute myeloid leukemia. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 65(6), pp. 834-842. Routledge 10.1080/01635581.2013.801998
Pabst, Thomas; Vellenga, Edo; van Putten, Wim; Schouten, Harry C; Graux, Carlos; Vekemans, Marie-Christiane; Biemond, Bart; Sonneveld, Peter; Passweg, Jakob; Verdonck, Leo; Legdeur, Marie-Cecile; Theobald, Matthias; Jacky, Emanuel; Bargetzi, Mario; Maertens, Johan; Ossenkoppele, Gert Jan; Löwenberg, Bob (2012). Favorable effect of priming with granulocyte colony-stimulating factor in remission induction of acute myeloid leukemia restricted to dose-escalation of cytarabine. Blood, 119(23), pp. 5367-73. Washington, D.C.: American Society of Hematology 10.1182/blood-2011-11-389841
von Grünigen, Isabelle; Raschle, Joëlle; Rüsges-Wolter, Ilka; Taleghani, Behrouz Mansouri; Mueller, Beatrice U; Pabst, Thomas (2012). The relapse risk of AML patients undergoing autologous transplantation correlates with the stem cell mobilizing potential. Leukemia research, 36(11), pp. 1325-9. Amsterdam: Elsevier 10.1016/j.leukres.2012.05.027
Mans, Sarah; Banz, Yara; Mueller, Beatrice U; Pabst, Thomas (2012). The angiogenesis inhibitor vasostatin is regulated by neutrophil elastase-dependent cleavage of calreticulin in AML patients. Blood, 120(13), pp. 2690-9. Washington, D.C.: American Society of Hematology 10.1182/blood-2012-02-412759
Ossenkoppele, Gert J; Stussi, Georg; Maertens, Johan; van Montfort, Kees; Biemond, Bart J; Breems, Dimitri; Ferrant, August; Graux, Carlos; de Greef, Georgine E; Halkes, C J M; Hoogendoorn, Mels; Hollestein, Rene M; Jongen-Lavrencic, Mojca; Levin, Mark D; van de Loosdrecht, Arjan A; van Marwijk Kooij, Marinus; van Norden, Yvette; Pabst, Thomas; Schouten, Harry C; Vellenga, Edo; ... (2012). Addition of bevacizumab to chemotherapy in acute myeloid leukemia at older age: a randomized phase 2 trial of the Dutch-Belgian Cooperative Trial Group for Hemato-Oncology (HOVON) and the Swiss Group for Clinical Cancer Research (SAKK). Blood, 120(24), pp. 4706-11. Washington, D.C.: American Society of Hematology 10.1182/blood-2012-04-420596
Cornelissen, Jan J; Breems, Dimitri; van Putten, Wim L J; Gratwohl, Alois A; Passweg, Jakob R; Pabst, Thomas; Maertens, Johan; Beverloo, H Berna; van Marwijk Kooy, Marinus; Wijermans, Pierre W; Biemond, Bart J; Vellenga, Edo; Verdonck, Leo F; Ossenkoppele, Gert J; Löwenberg, Bob (2012). Comparative analysis of the value of allogeneic hematopoietic stem-cell transplantation in acute myeloid leukemia with monosomal karyotype versus other cytogenetic risk categories. Journal of clinical oncology, 30(17), pp. 2140-6. Alexandria, Va.: American Society of Clinical Oncology 10.1200/JCO.2011.39.6499
Fos, José; Pabst, Thomas; Petkovic, Vibor; Ratschiller, Daniel; Mueller, Beatrice U (2011). Deficient CEBPA DNA binding function in normal karyotype AML patients is associated with favorable prognosis. Blood, 117(18), pp. 4881-4. Washington, D.C.: American Society of Hematology 10.1182/blood-2010-11-320747
Patterson, Andrew D; Maurhofer, Olivier; Beyoglu, Diren; Lanz, Christian; Krausz, Kristopher W; Pabst, Thomas; Gonzalez, Frank J; Dufour, Jean-François; Idle, Jeffrey R (2011). Aberrant lipid metabolism in hepatocellular carcinoma revealed by plasma metabolomics and lipid profiling. Cancer research, 71(21), pp. 6590-600. Birmingham, Ala.: American Association for Cancer Research AACR 10.1158/0008-5472.CAN-11-0885
Haefliger, Simon; Klebig, Christiane; Schaubitzer, Kerstin; Schardt, Julian; Timchenko, Nikolai; Mueller, Beatrice U; Pabst, Thomas (2011). Protein disulfide isomerase blocks CEBPA translation and is up-regulated during the unfolded protein response in AML. Blood, 117(22), pp. 5931-40. Washington, D.C.: American Society of Hematology 10.1182/blood-2010-08-304485
Löwenberg, Bob; Pabst, Thomas; Vellenga, Edo; van Putten, Wim; Schouten, Harry C; Graux, Carlos; Ferrant, Augustin; Sonneveld, Pieter; Biemond, Bart J; Gratwohl, Alois; de Greef, Georgine E; Verdonck, Leo F; Schaafsma, Martijn R; Gregor, Michael; Theobald, Matthias; Schanz, Urs; Maertens, Johan; Ossenkoppele, Gert J (2011). Cytarabine dose for acute myeloid leukemia. New England journal of medicine NEJM, 364(11), pp. 1027-36. Waltham, Mass.: Massachusetts Medical Society MMS
Schardt, Julian A; Mueller, Beatrice U; Pabst, Thomas (2011). Activation of the unfolded protein response in human acute myeloid leukemia. Methods in enzymology, 489, pp. 227-243. New York, N.Y.: Academic Press 10.1016/B978-0-12-385116-1.00013-3
Eyholzer, Marianne; Schmid, Sabine; Schardt, Julian A; Haefliger, Simon; Mueller, Beatrice U; Pabst, Thomas (2010). Complexity of miR-223 regulation by CEBPA in human AML. Leukemia research, 34(5), pp. 672-6. Amsterdam: Elsevier 10.1016/j.leukres.2009.11.019
Bonadies, Nicola; Pabst, Thomas; Mueller, Beatrice U (2010). Heterozygous deletion of the PU.1 locus in human AML. Blood, 115(2), pp. 331-4. Washington, D.C.: American Society of Hematology 10.1182/blood-2009-03-212225
Schardt, Julian A; Eyholzer, Marianne; Timchenko, Nikolai A; Mueller, Beatrice U; Pabst, Thomas (2010). Unfolded protein response suppresses CEBPA by induction of calreticulin in acute myeloid leukaemia. Journal of Cellular and Molecular Medicine, 14(6B), pp. 1509-0519. Bucharest (Romania): Wiley 10.1111/j.1582-4934.2009.00870.x
Mueller, Beatrice U; Pabst, Thomas (2010). Lineage-specific transcription factor aberrations in AML. Cancer treatment and research, 145, pp. 109-125. New York, N.Y.: Springer Science+Business Media
Eich, Hans Theodor; Diehl, Volker; Görgen, Helen; Pabst, Thomas; Markova, Jana; Debus, Jürgen; Ho, Anthony; Dörken, Bernd; Rank, Andreas; Grosu, Anca-Ligia; Wiegel, Thomas; Karstens, Johann Hinrich; Greil, Richard; Willich, Normann; Schmidberger, Heinz; Döhner, Hartmut; Borchmann, Peter; Müller-Hermelink, Hans-Konrad; Müller, Rolf-Peter and Engert, Andreas (2010). Intensified chemotherapy and dose-reduced involved-field radiotherapy in patients with early unfavorable Hodgkin's lymphoma: final analysis of the German Hodgkin Study Group HD11 trial. Journal of clinical oncology, 28(27), pp. 4199-206. Alexandria, Va.: American Society of Clinical Oncology 10.1200/JCO.2010.29.8018
Löwenberg, Bob; Beck, Joachim; Graux, Carlos; van Putten, Wim; Schouten, Harry C; Verdonck, Leo F; Ferrant, Augustin; Sonneveld, Pieter; Jongen-Lavrencic, Mojca; von Lilienfeld-Toal, Marie; Biemond, Bart J; Vellenga, Edo; Breems, Dimitri; de Muijnck, Hilde; Schaafsma, Ron; Verhoef, Gregor; Döhner, Hartmut; Gratwohl, Alois; Pabst, Thomas; Ossenkoppele, Gert J; ... (2010). Gemtuzumab ozogamicin as postremission treatment in AML at 60 years of age or more: results of a multicenter phase 3 study. Blood, 115(13), pp. 2586-91. Washington, D.C.: American Society of Hematology 10.1182/blood-2009-10-246470
Novy, Jan; Rosselet, Anne; Spertini, Olivier; Lobrinus, Johannes Alexander; Pabst, Thomas; Kuntzer, Thierry (2010). Chemotherapy is successful in sporadic late onset nemaline myopathy (SLONM) with monoclonal gammopathy. Muscle & nerve, 41(2), pp. 286-7. New York, N.Y.: John Wiley & Sons 10.1002/mus.21560
Weininger, Markus; Lauterbach, Brigitte; Knop, Stefan; Pabst, Thomas; Kenn, Werner; Hahn, Dietbert; Beissert, Matthias (2009). Whole-body MRI of multiple myeloma: comparison of different MRI sequences in assessment of different growth patterns. European journal of radiology, 69(2), pp. 339-45. Stuttgart: Thieme 10.1016/j.ejrad.2007.10.025
Löwenberg, Bob; Ossenkoppele, Gert J; van Putten, Wim; Schouten, Harry C; Graux, Carlos; Ferrant, Augustin; Sonneveld, Pieter; Maertens, Johan; Jongen-Lavrencic, Mojca; von Lilienfeld-Toal, Marie; Biemond, Bart J; Vellenga, Edo; van Marwijk Kooy, Marinus; Verdonck, Leo F; Beck, Joachim; Döhner, Hartmut; Gratwohl, Alois; Pabst, Thomas; Verhoef, Gregor (2009). High-dose daunorubicin in older patients with acute myeloid leukemia. New England journal of medicine NEJM, 361(13), pp. 1235-48. Waltham, Mass.: Massachusetts Medical Society MMS 10.1056/NEJMoa0901409
Pabst, Thomas; Mueller, Beatrice U (2009). Complexity of CEBPA dysregulation in human acute myeloid leukemia. Clinical cancer research, 15(17), pp. 5303-7. Philadelphia, Pa.: American Association for Cancer Research 10.1158/1078-0432.CCR-08-2941
Schardt, Julian A; Weber, Daniel; Eyholzer, Marianne; Mueller, Beatrice U; Pabst, Thomas (2009). Activation of the unfolded protein response is associated with favorable prognosis in acute myeloid leukemia. Clinical cancer research, 15(11), pp. 3834-41. Philadelphia, Pa.: American Association for Cancer Research 10.1158/1078-0432.CCR-08-2870
Adès, Lionel; Sanz, Miguel A; Chevret, Sylvie; Montesinos, Pau; Chevallier, Patrice; Raffoux, Emmanuel; Vellenga, Edo; Guerci, Agnès; Pigneux, Arnaud; Huguet, Francoise; Rayon, Consuelo; Stoppa, Anne Marie; de la Serna, Javier; Cahn, Jean-Yves; Meyer-Monard, Sandrine; Pabst, Thomas; Thomas, Xavier; de Botton, Stéphane; Parody, Ricardo; Bergua, Juan; ... (2008). Treatment of newly diagnosed acute promyelocytic leukemia (APL): a comparison of French-Belgian-Swiss and PETHEMA results. Blood, 111(3), pp. 1078-84. Washington, D.C.: American Society of Hematology 10.1182/blood-2007-07-099978
Pabst, Thomas; Eyholzer, Marianne; Haefliger, Simon; Schardt, Julian; Mueller, Beatrice U (2008). Somatic CEBPA mutations are a frequent second event in families with germline CEBPA mutations and familial acute myeloid leukemia. Journal of clinical oncology, 26(31), pp. 5088-93. Alexandria, Va.: American Society of Clinical Oncology 10.1200/JCO.2008.16.5563
Kirstetter, Peggy; Schuster, Mikkel B; Bereshchenko, Oksana; Moore, Susan; Dvinge, Heidi; Kurz, Elke; Theilgaard-Mönch, Kim; Månsson, Robert; Pedersen, Thomas A; Pabst, Thomas; Schrock, Evelin; Porse, Bo T; Jacobsen, Sten Eirik W; Bertone, Paul; Tenen, Daniel G; Nerlov, Claus (2008). Modeling of C/EBPalpha mutant acute myeloid leukemia reveals a common expression signature of committed myeloid leukemia-initiating cells. Cancer cell, 13(4), pp. 299-310. Cambridge, Mass.: Cell Press 10.1016/j.ccr.2008.02.008
Pabst, Thomas; Stillner, Erica; Neuberg, Donna; Nimer, Stephen; Willman, Cheryl L; List, Alan F; Melo, Junia V; Tenen, Daniel G; Mueller, Beatrice U (2006). Mutations of the myeloid transcription factor CEBPA are not associated with the blast crisis of chronic myeloid leukaemia. British journal of haematology, 133(4), pp. 400-2. Oxford: Wiley-Blackwell 10.1111/j.1365-2141.2006.06057.x
Mueller, Beatrice U; Pabst, Thomas (2006). Cutaneous zygomycosis at catheter insertion site in AML-M4Eo. Annals of hematology, 85(3), pp. 194-5. Berlin: Springer-Verlag 10.1007/s00277-005-0053-5
Mueller, Beatrice U; Pabst, Thomas; Fos, José; Petkovic, Vibor; Fey, Martin F; Asou, Norio; Buergi, Ulrich; Tenen, Daniel G (2006). ATRA resolves the differentiation block in t(15;17) acute myeloid leukemia by restoring PU.1 expression. Blood, 107(8), pp. 3330-8. Washington, D.C.: American Society of Hematology 10.1182/blood-2005-07-3068
Mueller, Beatrice U; Pabst, Thomas (2006). C/EBPalpha and the pathophysiology of acute myeloid leukemia. Current opinion in hematology, 13(1), pp. 7-14. Hagerstown, Md.: Wolters Kluwer Lippincott Williams & Wilkins 10.1097/01.moh.0000190110.08156.96
Jeker, Barbara; Daskalakis, Michael; Zeerleder, Sacha; Pabst, Thomas; Novak, Urban (January 2021). CAR T Cells: Immuntherapie mit grossem Potenzial. Onkologie & Hämatologie, 2021, pp. 16-19. Prime Public Media AG
Riether, Carsten; Pabst, Thomas; Höpner, Sabine; Bacher, Vera; Hinterbrandner, Magdalena; Banz, Yara; Müller, Rouven; Manz, Markus G.; Gharib, Walid H.; Ferreira, David; Bruggmann, Remy; Van Rompaey, Luc; Moshir, Mahan; Delahaye, Tim; Gandini, Domenica; Erzeel, Ellen; Hultberg, Anna; Fung, Samson; De Haard, Hans; Leupin, Nicolas; ... (2 December 2018). 2680 Argx-110 Targeting CD70, in Combination with Azacitidine, Shows Favorable Safety Profile and Promising Anti-Leukemia Activity in Newly Diagnosed AML Patients in an Ongoing Phase 1/2 Clinical Trial (Unpublished). In: ASCO 2018. 2. Dezember 2018.
Funke, Manuela; Schäfer, Stephan; Pabst, Thomas; Geiser, Thomas; Pachlopnik Schmid, J; Dahinden, Clemens A.; Zimmerli, Stefan (May 2014). Necrotizing mediastinal lymphadenopathy due to disseminated M. abcessus infection revealing MonoMAc Syndrome - a case report (Unpublished). In: Annual Meeting of the Swiss Society for Pneumology. Interlaken. 08.-09.05.2014.
Funke, Manuela; Schäfer, Stephan; Pabst, Thomas; Geiser, Thomas; Pachlopnik Schmid, J; Dahinden, Clemens A.; Zimmerli, Stefan (May 2014). Necrotizing mediastinal lymphadenopathy due to disseminated M. abcessus infection recealing MonoMAc Syndrome - a case report (Unpublished). In: Annual Meeting of the Swiss Society for Pneumology. Interlaken. 08.-09.05.214.
Messikomer, A; Bruktawit, M; Seipel, Katja; Valk, P; Theocharides, A; Pabst, Thomas; Mckeague, M; Luedtke, N (25 May 2021). Cancer Prognosis According to Parthanatos Features (bioRxiv). Cold Spring Harbor Laboratory 10.1101/2021.05.24.445484
